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Summary  
 
In order to grow and survive the human malaria parasite Plasmodium falciparum 
synthesizes and exports hundreds of proteins in order to modify the infected red blood 
cell. In previous studies, our group found that two members of parasite encoded type II 
Hsp40s (PEF55, PFA660) associate with highly mobile structure in the infected host 
cell, which are referred to as J-dots. Furthermore, an exported parasite chaperone, 
PfHsp70x was identified which also associated with these structures. To understand 
the role of J-dots in host cell modification, we aimed to purify J-dots and identify the 
proteome of these parasite-induced intra-erythrocytic structures. This would allow us to 
further construct a protein-protein interactions network of the P. falciparum infect red 
blood cell. 
 
In this study, multiple proteomics methods were used to profile PFE55-PfHsp70x 
chaperone/co-chaperone protein complexes (J-dots). By using differential 
centrifugation as well as immunoblotting of BN-PAGE and 2D BN/SDS PAGE, PFE55 
and PfHsp70x were visualized in the same complex with a high molecular weight 
>223KDa. Furthermore, two exported proteins, PfPHISTc and PfGEXP18 were 
identified by co-immunoprecipitation (co-IP) and LC-MS/MS to interact with PFE55 and 
PfHsp70x, and subsequently to localize to J-dots In addition, further protein complexes 
containing PFE55 and PfHsp70x were found not only in the parasite infected 
erythrocyte cytosol but also in the parasitophorous vacuole. Surprisingly, PfHsp70x 
was also found associated with a protein translocon at the parasitophorous vacuole, 
termed PTEX. Proteomic analysis of the co-IP also suggested an interaction between 
human Hsp70 and PFE55. Taken together, our data indicates PfHsp70x-PFE55 
chaperones/co-chaperone complexes are involved in exported protein trafficking from 
the parasitophorous vacuole into the erythrocyte cytosol. Potentially, these complexes 
could be aiding in protein folding and unfolding during passage through the PTEX 
translocon. Moreover, the fact that many exported proteins were found associated with 
PfHsp70x, further highlights the role of PfHsp70x in coordinating exported protein 
trafficking.  
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Zusammenfassung 
Der humane Malaria Parasit Plasmodium falciparum ist für sein Überleben darauf 
angewiesen die von ihm infizierten Erythrozyten mittels exportierter Proteine zu 
modifizieren. In vorausgehenden Studien konnte gezeigt werden, dass zwei parasiten- 
codierte Typ II Hsp40s (PEF55, PFA660) mit mobilen Strukturen in der Wirtszelle, den 
sogenannten J-dots, assoziieren. Außerdem konnte ein exportiertes Chaperon des 
Parasiten PfHsp70x identifiziert werden, dass ebenfalls mit diesen Strukturen 
assoziiert. Ziel dieser Arbeit ist es J- dots aufzureinigen und deren Proteom zu 
bestimmen, um die Funktion dieser parasitären Strukturen im Wirtszellcytosol für die 
Modifikation der Wirtszelle besser zu verstehen. Das könnte uns ermöglichen, weitere 
Teile des komplexen Netzwerks aus Protein-Protein Interaktionen in P. falciparum 
infizierten Erythrozyten zu entziffern. 
In dieser Arbeit wurden mehrere Methoden benutzt, um das Proteom der PFE55-
PfHsp70x Ko-Chaperon- Chaperon Komplexe (J-dots) zu bestimmen. Dabei konnte 
durch differentielle Zentrifugation und Immunoblot von BN-PAGE und 2D BN/SDS 
PAGE gezeigt werden, dass PFE55 und PfHsp70x Teil eines Komplexes mit hoher 
molekularer Masse (>223 kDa) sind. Außerdem konnten mittels Ko-Immunpräzipitation 
und LC- MS/MS zwei exportierte Proteine identifiziert werden, die mit PFE55 und 
PfHsp70x interagieren und ebenfalls mit J-Dots assoziieren: PfPHISTc und PfGEXP18. 
Zusätzlich wurden PFE55 und PfHsp70x nicht nur in Komplexen im Zytosol der 
infizierten Erythrozyten sondern auch in weiteren Komplexen in der parasitophoren 
Vakuole nachgewiesen. Außerdem tritt PfHsp70x überraschender Weise auch in 
Assoziation mit einem Translokon in der parasitophoren Vakuole (PTEX) auf. Des 
Weiteren weißt die proteomische Analyse der Ko-Immunpräzipitation auf eine 
Interaktion von PFE55 und humanem Hsp70 hin.   
Insgesamt zeigen unsere Daten, dass PfHsp70x und PFE55 als Chaperon- Ko-
Chaperon Komplexe am Transport von exportierten Proteinen durch das PTEX 
Translokon an der parasitophoren Vakuole beteiligt sind. Dabei könnten sie 
insbesondere bei der Entfaltung und Faltung von Proteinen während dem Export durch 
das PTEX Translokon eine Rolle spielen. Zusätzlich unterstreicht die Vielzahl an 
exportierten Proteinen, die mit PfHsp70x interagieren die Rolle, die dieses Chaperon in 
der Koordination des Proteinexports von P. falciparum spielt. 
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1 INTRODUCTION 
 Malaria 1.1
Malaria is one of the most serious fatal blood diseases in the world. Nearly half of the 
world population living in the endemic areas has been infected, include South America, 
Africa and Indonesia, covering more than 100 countries. In 2013, an estimated 198 
million cases of malaria occurred worldwide with 584,000 to 855,000 people dead. 
Over 90% of these cases happened in Africa; majority of them were children with a 
burden occurring age younger than 5 years old (WHO, 2014). Malaria is caused by 
parasites that are transmitted from the bites of female Anopheles mosquito. These 
parasites are transferred from mosquito’s saliva into human blood steams after biting 
then travel to human livers for maturation and reproduction. There are five different 
species of the genus Plasmodium known to cause malaria, including Plasmodium vivax, 
Plasmodium ovale, Plasmodium malariae, P falciparum and Plasmodium knowlesi. 
Among them, P. falciparum leads to the most fatal infection; while P. vivax, P. ovale, 
and P. malariae generally cause a milder form of malaria that is rarely fatal. Additionally, 
P. knowlesi mostly causes the disease in macaques; however, recently, it has been 
also found to infect human (Singh et al., 2004). 
 Overview of the P. falciparum life cycle 1.2
P. falciparum has a complicated life cycle includes multiple reproduction stages in 
human host cells. In general, sporozoites migrate into the host during the bite of the 
female Anopheles mosquito, then enter the bloodstream and eventually get into the 
liver cell, which is referred as the exo-erythrocytic stage. In the liver cell, the 
sporozoites re-differentiate and release thousands of merozoites into the bloodstream. 
Next, once the merozoites invade the red blood cell successfully, the erythrocytic stage 
starts. The invasion is a fast process that takes approximately 60 seconds for escaping 
the immune detection and invading the red blood cell. The invasion is accomplished via 
the interaction between merozoite surface proteins and red blood cell membrane 
surface proteins. After invasion, parasites replicate and go through three distinct stages 
including ring, trophozoite and schizont stages. One merozoite can reproduce 20-30 
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daughters in 48 hours. First of all, merozoite grows from ring like stage by take the 
hemoglobin as nutrition (0-12 hours after invasion) into more mature trophozoites (12-
30 hours), afterwards, the nucleus of trophozoite is divided and become multinucleated 
schizont (30-48 hours) (Shortt, 1951), followed by growing into many individual 
merozoite forms. Once the red blood cell is ruptured, merozoites are released in order 
to invade new red blood cells and restart a new life cycle (Cowman and Crabb, 2006). 
Moreover, parasites can also commit to the asexual stage by differentiating into male 
or female gametocytes, the sexual form of parasites is able to stay in the host for 60 
days without any further development except been taken by mosquito for complete P. 
falciparum cycle by development in the mosquito midgut (mosquito stage) (figure 1.1) 
(Talman et al., 2004; Alano, 2007; Ay et al., 2015). 
As malaria parasites rapidly reproduce and spread in the erythrocyte and blood stream, 
and export Erythrocyte Membrane Protein-1 (PfEMP1) to the red blood cell membrane 
surface lead to infected erythrocytes cytoadherence. Many symptoms appear on 
infected hosts, such as coldness or fever, significantly reduced or even halted blood 
flows due to the cytoadherence of infected erythrocytes. All of these are vital to body 
organs such as hearts, lungs, and kidneys. For some serious form of malaria, there is 
even the brain function deficiency, which can lead to convulsions, paralysis, coma and 
even death (Idro et al., 2010). 
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Figure 1.1: P.  falciparum life cycle overview. 
During the bite of mosquito, malaria parasites migrate into the human host. Asexual reproduction occurs in 
live cell; then merozoites invade into red blood cells and develop through ring, trophozoite and schizonet 
stages and finally are released from host cells to initial a new invasion cycle. (Ay et al., 2015)  
 Intraerythrocytic stages of P. falciparum 1.3
1.3.1 The function of novel structures in P. falciparum infected 
red blood cell 
There are several structures and compartments formed during the development and 
maturation of the parasite in the red blood cell (Figure 1.2). First of all, parasitophorous 
vacuole (PV) is present in some apicomplexan parasites such as Toxoplasma and 
Plasmodium and formed during merozoite invasion, which surrounds the parasite as a 
barrier between it and the host cell. The parasite reproduces and develops inside the 
PV. It is suggested that PV is involved in the parasite nutrition uptake as well as 
protecting the parasite from erythrocyte cytosol potentially harmful substances (Lauer 
et al., 2000; Murphy et al., 2004). Also many proteases and chaperones have been 
found in PV by proteome studies; and these proteins are likely involved in many 
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processes such as nutrient acquisition and parasite release (Lingelbach and Joiner, 
1998; Lauer et al., 2000; Marti et al., 2004; Murphy et al., 2004). Surrounding the side 
PV, there is a membrane compartment so-called parasitophorous vacuole membrane 
(PVM); however, it is still under debate whether the source of PVM is from human red 
blood cell membrane or the or parasite origin is still in a debate (Bannister and 
Dluzewski, 1990). In addition, there is a set of membranous network called 
tubovesicular network (TVN) locating at the erythrocyte cytosol (van Ooij et al., 2008), 
which seems to connect with PVM and plays a role in the nutrient acquisition (Atkinson 
and Aikawa, 1990). Another unique, complex structure likely generated from PVM or 
TVN and formed in parasites during erythrocyte infection, is called Maurer’s clefts. This 
structure has a diameter of ~30nm, consisting of an electron-dense coat and a 
translucent lumen. It is most likely close to the erythrocyte membrane and has been 
revealed to be associated with several parasite encode export proteins such as 
PfEMP1, RIFIN and SURFIN during their delivery to the red blood cell membrane 
surface, indicating its function to help deliver export proteins through red blood cell 
(Tobie and Coatney, 1961; Aikawa et al., 1986; Waterkeyn et al., 2000; Przyborski et 
al., 2005; Lanzer et al., 2006).  
Since malaria parasites are known to export more than 400 hundreds protein to the 
infected erythrocyte in order to modify the morphology, physiology and function of the 
host cell, it is essential for parasites to make sure these proteins cross not only parasite 
plasma membrane (PPM) but also the PVM (Marti et al., 2005; Sargeant et al., 2006; 
Maier et al., 2008). The transport to the PV is usually accomplished by going through 
endoplasmic reticulum (ER), a classical secretory system; and these proteins contain a 
hydrophobic sequence at the N-terminus similar as the signal peptide (Blobel and 
Dobberstein, 1975; Blobel and Dobberstein, 1975; Kirchhausen, 2000). Recently, a 
novel translocon of exported proteins complex (PTEX) is found to be located at PVM, 
which may play an important role for protein transport from PV to erythrocyte cytosol 
(de Koning-Ward et al., 2009; Beck et al., 2014; Elsworth et al., 2014). 
 
Introduction  
 5 
                           
 
Figure 1.2: The structure of malaria parasites in the host cell.  
N: nucelus; PV: parasitophorous vacuole; PVM: parasitophorous vacuole membrane; PPM: parasite 
plasma membrane; MC: Maurer's clefts; NPP: new permeation pathways in the red blood cell membrane; 
V: transport vesicles and protein aggregates; mCS: modified cytoskeleton of the red blood cell; Knobs; 
structures on the host cell surface 
 
1.3.2 Modification of the host cell by P. falciparum exported 
protein 
Parasites have to modify the infected red blood cell for escaping human immune 
system in order to develop and reproduce inside. For these purposes, parasites export 
many proteins to the membrane surface of red blood cells, which form an electron- 
microscopically visible, sticky structure referred as “Knobs” during plasmodium 
trophozoite stage change the morphology, physiology and function of infected red 
blood cells (Leech et al., 1984).  So far, there are several of these surface proteins 
identified, such as P. falciparum-infected erythrocyte membrane protein-1 (PfEMP-1), P. 
falciparum-infected erythrocyte membrane protein-2 (PfEMP2), erythrocyte membrane 
protein-3 (PfEMP-3) as well as submembranous structural proteins knob-associated 
histidine-rich protein (KAHRP) that is essential for Knobs conformation (Pologe and 
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Ravetch, 1986; Pasloske et al., 1993; Crabb et al., 1997; Waller et al., 1999; Smith, 
2014). PfEMP-1 is a protein with a molecular weight of 200-350KDa that is responsible 
for the adhesion of infected erythrocytes to the endothelial lining of blood vessels. 
Since membrane surface proteins like PfEMP-1 can adhere together to endothelial 
cells in the blood vessel, the blood stream flow is significantly reduced or even 
completely halted; as a result, lots of organs such as heart, lung, kidney and brain fail 
to function properly (Grau et al., 1990; Baruch et al., 1995; Smith et al., 2000; Miller et 
al., 2002; Maier et al., 2009). Therefore, the Knob proteins are important for the malaria 
parasites to escape from immunotherapeutic agents, suggesting that these proteins are 
a hot research topic for malaria remedy.  
1.3.3 P. falciparum proteins transport  
Once the parasites invade into erythrocyte, hundreds of proteins are exported to modify 
the host cell for parasite survival.  Up to 8% of the parasite’s gene products contain a 
five amino acid motif sequence (RxLxE/D/Q) called PEXEL/HT (Protein Export 
Element/Host targeting motif). This sequence is located ~35 amino acids downstream 
from the signal peptide and can be cleaved by the enzyme plasmepsin V in order to 
produce the mature protein. The PEXEL motif can be used to predict exported proteins 
(Hiller et al., 2004; Marti et al., 2005; Sargeant et al., 2006; Chang et al., 2008; Boddey 
et al., 2009; Maier et al., 2009). Exported proteins have various destinations including 
the cytoplasm of host red blood cells, Maurer's cleft, as well as the erythrocyte 
membrane (Maier et al., 2009). This unique export element defines the secretome; 
however, the principle of the secretion pathway is still not fully understood. Particularly, 
this PEXEL/HT peptide sequence shares between soluble and membrane proteins. 
Another type of exported proteins, which lacks the PEXEL motif sequence but can still 
export to the cytoplasm, is called PEXEL-negative exported proteins (PNEPs). This 
group of protein includes skeleton binding protein 1(SBP1) and membrane associated 
histidine-rich protein (MAHRP1). By far, its export mechanism is also not clear (Blisnick 
et al., 2000; Spielmann et al., 2006; Maier et al., 2009). Recent studies found that a 
new Plasmodium translocon of exported proteins (PTEX) on PVM was responsible for 
exporting both PEXEL-containing proteins and PNEP proteins to the cytoplasm of the 
infected cell (de Koning-Ward et al., 2009; Gruring et al., 2012; Beck et al., 2014; 
Elsworth et al., 2014). 
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1.3.4 Plasmodium translocon of exported proteins (PTEX) 
In order to reach the erythrocyte cytosol, the exported proteins are supposed to cross 
parasitophorous vacuole membrane (PVM) by going through a specific translocon. 
Proteome analysis of lipid-raft-like, detergent resistant membrane fractions of parasites 
revealed a majority of PVM proteins. This suggests that the components of the 
translocon are PVM proteins (de Koning-Ward et al., 2009). By co-immunoprecipitation 
and the LC-MS/MS identification, it has been found that Plasmodium translocon of 
exported proteins (PTEX) is a protein complex locating at PVM, which consists of five 
proteins. Among them, a heat shock protein 101 (Hsp101) is a ClpB-like AAA+ ATPase 
component of PTEX, providing the power to unfold the protein going through the 
channel formed on the PVM by export protein 2 (EXP2), a PVM protein. Another 
partner, PTEX 150, seems to directly associate with EXP2 and a small thioredoxin-like 
protein (TRX2) that assist protein oxidation and reduction, as well as an unknown 
protein PTEX88 (Figure 1.3) (de Koning-Ward et al., 2009; Elsworth et al., 2014). This 
PTEX translocon can help exported protein cross the membrane for entering the 
infected erythrocytes (de Koning-Ward et al., 2009). It has been found that Hsp101 was 
more likely binding with exported protein than others, which indicated that Hsp101 
played a role in associating with exported proteins and serving as protein cargos for the 
secretion (Bullen et al., 2012). To verify the function of PTEX translocon, several 
knockdown cell lines were generated. In the PTEX150 knockdown parasite cells, the 
expression level of P. falciparum-infected erythrocyte membrane protein-1 (PfEMP-1) 
on the surface was found to be lower. By knocking down Hsp101, PEXEL contain 
proteins REX3 and KAHRP transport were found be blocked in the infected red blood 
cell while the PNEP protein export has also been blocked like REX1 (Ring-exported 
protein 1) (Beck et al., 2014; Elsworth et al., 2014; Molloy, 2014). However, the 
mechanism and function of PTEX translocon remains poorly understood For instance, 
how the PTEX translocon recognizes and selectively allows some of the proteins 
passing through; while the other proteins remain in parasitophorous vacuole? Also, 
since exported proteins have to keep unfolded for going through the translocon and 
refold after crossing PVM, it is still not clear whether Hsp101 or other chaperones 
assist it (Gehde et al., 2009; Gruring et al., 2012). 
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Figure 1.3: location and composition of PTEX translocon in the infected 
erythrocyte.  
PTEX translocon localizes at PVM and consists of five subunits: EXP2, Hsp101, PTEX150, PTEX88, 
TRX2, and EXP2. EXP2 forms the pore in the PVM; while Hsp101 unfolds the protein before translocation. 
PTEX150 forms the structure of PTEX. TRX2 assists protein oxidation and reduction and helps to regulate 
PTEX. The function of PTEX88 remains unknown (Elsworth et al., 2014). 
 
 Important heat shock proteins in P. falciparum 1.4
Heat shock proteins are a family of proteins produced to response to the environmental 
stress (Ritossa, 1962; Matz et al., 1995; Cao et al., 1999). Many of these heat shock 
proteins act as chaperones and are essential for many cellular processes including 
protein folding, unfolding, protein trafficking as well as repair of proteins upon damage 
under stress condition like UV radiation, cold, or oxidative stress (De Maio, 1999). 
Normally, heat shock proteins (Hsp) are named according to molecular weight, such as 
Hsp60, Hsp70, Hsp90, and Hsp110. Some of heat shock proteins function as 
chaperones or co-chaperones such as Hsp40 and Hsp70. These two Hsps assist 
protein folding and prevent proteins from abnormal aggregation (Walter and Buchner, 
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2002; Li and Srivastava, 2004; Kampinga and Craig, 2010). Recent studies suggest 
that Plasmodium encode export Hsp40s and Hsp70s that are involved in many cellular 
processes during the infection, including cell cycle regulation and signal transduction 
(Botha et al., 2007; Shonhai et al., 2007).  
1.4.1 P. falciparum encodes Hsp40  
P. falciparum genome encodes Hsp40 that can be divided into four classes. Type I 
Hsp40 contains J-domain that is crucial for interacting with Hsp70, Gly/Phe-rich region 
(GF domain), and a Zinc finger but without any export element. It has a chaperone 
function in the parasite (Mayer et al., 1999; Rug and Maier, 2011). Type II Hsp40 has 
the J domain and Zinc domain but lack the cysteine-rich domain (Botha et al., 2007), 
there are eight Hsp40 belonging to type II, with three of them having an export motif 
(PFA0660w, PFB0090c, and PFE0055c) (Bhattacharjee et al., 2008). Most of the 
Hsp40s belong to type III, which has only a J domain. Some of them have a predicted 
export element; while the others lack a PEXEL sequence (Young et al., 2004). Type IV 
has a J domain as well as a HPD tripeptide; this type of Hsp40 is parasite specific with 
no homolog in human; and its function is hypothesized to be function differently from 
other types, there are ten out of the total twenty molecular Hsp40 with a export element 
(Cheetham and Caplan, 1998; Botha et al., 2007). Recently studies reveal that 
PFE0055c (referred to as PFE55) as well as PFA0660W (referred to as PFEA660) 
localize at the parasite-infected erythrocyte as a highly mobile dot structure that is 
referred as J-dots; moreover, these two proteins co-localize with parasite-encoded 
PfHsp70x, but not with any known Maurer's clefts markers. So far, the function and 
composition of J-dots are not yet clear (Kulzer et al., 2010; Kulzer et al., 2012). There 
is a hypothesis that type II Hsp40 proteins possibly interact with the human-encoded 
Hsp70 since they are homologous with the human DnaJB4 gene; however, no direct 
evidence has been found. Some non-exported type II Hsp40s also have been found to 
interact with cytosolic parasite-encoded Hsp70s, such as Pfj4 interacting with Hsp70-1 
(Pesce et al., 2008; Rug and Maier, 2011). 
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1.4.2  P. falciparum heat shock proteins 70 (PfHsp70s) 
P. falciparum heat shock proteins 70 (PfHsp70s) are important chaperones critical for 
protein folding, refolding, degradation, and especially for transporting exported proteins 
into the infected red blood cell (Shonhai et al., 2007; Njunge et al., 2013). There are six 
Hsp70 proteins identified in the P. falciparum life: Hsp70-1, Hsp70-2, Hsp70-3 and 
Hsp70x, y, z (Njunge et al., 2013). PfHsp70-1 is a cytosolic protein locating at cytosol 
or nucleus and plays a role as the co-chaperone with the parasite-encoded Hsp90 for 
the stress response (Gitau et al., 2012). PfHsp70-2 is PfHsp70-1’s endoplasmic 
reticulum homolog. PfHsp70-1, PfHsp70-2 and PfHsp90 form as various isoforms by 
different post-translational modification (Foth et al., 2011). PfHsp70-y and PfHsp70-z 
belong to Grp110.Grp170 (Hsp110) group, PfHsp70-y localizes at ER and is possibly 
responsible for the protein quality control (Shonhai et al., 2007). PfHsp70-z acts as 
nucleotide exchange factors (NEF) to facilitate the nucleotide exchange function of 
PfHsp70-1 (Shonhai et al., 2007). PfHsp70x is only identified in two Laverania 
subgenus malaria parasite, P. falciparum and chimpanzee parasite Plasmodium 
reichenowi (Kulzer et al., 2012). PfHsp70x contains an ER signal peptide with a C-
terminal region, and is found to locate at the PV as well as cytosol erythrocyte. 
PfHsp70x is highly expressed in the early ring stage; and its protein level reaches the 
peak during the schizonts stage. PfHsp70x lack the PEXEL/HT motif; while the peptide 
from 25 to 32 amino acids seems be responsible for its export (Hiller et al., 2004; 
Grover et al., 2013; Przyborski et al., 2015). Recently, it has been found that PfHsp70x 
co-localizes with parasite Hsp40 that as known as J-dots (Kulzer et al., 2010; Kulzer et 
al., 2012).  
1.4.3 A novel structure in parasite infected erythrocyte  
There is a novel uncharacterized highly mobile structure that is identified in cytosol of 
P. falciparum-infected red blood cell recently (Kulzer et al., 2010). This structure 
contain two exported type II Hsp40s (PFE0055c, PFA660w) which showed by 
immunofluorescence and not marked by Maurer’s marker and already visible in the ring 
stage, as refers as J-dots since the Hsp40 have a J domain (Kulzer et al., 2010). 
Investigations have revealed that the outer side of the J-dots is derived from parasite 
Hsp40 (Kulzer et al., 2010). In addition, co-immunoprecipitation and 
immunofluorescence assays show that parasite-derived Hsp70x directly interacts and 
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partially co-localizes with PEF0055c as well as PFA660w (Kulzer et al., 2012) (Figure 
1.4). This chaperone/co-chaperone structure (PFA0660w/PFE0055c-PfHsp70x) may 
be involved in the intracellular or intercellular protein trafficking and responsible for the 
protein folding, unfolding and trafficking within the infected red blood cell cytosol 
(Kulzer et al., 2012; Grover et al., 2013). Formation of 30nm pores in the membrane of 
infected erythrocytes by Streptolysin O permeabilization failed to isolate the J-dots 
indicating that the J-dots are greater than 30nm (Kulzer et al., 2012). 
Immunofluorescence assay also revealed that PfEMP1 and J-dots partially co-localized 
during the early stage, which indicated that J-dots were possibly involved in PfEMP1 
transport through the infected erythrocytes (Kulzer et al., 2012). A merger with the cell 
membrane of the host cell could also not be observed, which seems the J-dots not to 
be anchored in the infected erythrocytes. The exact composition and function of J-dots 
remain unclear. 
As known that the parasite-encoded exported proteins are involved in the host cell 
modification process (Maier et al., 2008). In particular, a set of proteins that are 
transported to the surface of red blood cells hold responsibility for the cytoadhesion 
and immune evasion of host cells (Maier et al., 2008). To ensure the proper protein 
transport to the erythrocyte cytosol or the red blood cell membrane, parasite-secreted 
proteins have to cross the parasite membrane by un-folding and refolding after passing 
the membrane (Gehde et al., 2009). Furthermore, exported heat shock proteins are 
implicated to work as chaperones that mediate the protein translocation, folding and 
unfolding (Przyborski et al., 2015). 
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Figure 1.4: A novel structure was found in the parasite infected erythrocyte 
cytosol contained PFA660w/PFE055c-PfHsp70x referred as J-dots.  
Co-localization of PfHsp70x and exported Hsp40s (PFE55/PFA660w), Fluorescence channels are shown 
individually in black and white, co-localization was indicated in merge and overlay. The analysis was 
performed using monoclonal anti-GFP (green) and polyclonal anti-PfHsp70x (red) (Kulzer et al., 2012). 
 Protein-protein interactions studies 1.5
Proteomics is a large-scale study on functions and structures of proteins (Wilkins, 
2009). It focuses on the dynamics of gene regulation, quantities of the protein 
expression, the identification of the impact on disease and drug (Heath et al., 2015). All 
of subjects study base on protein structure and function study to illuminate the changes 
of the life mechanisms under pathological condition (Tyers and Mann, 2003). 
Many aspects have to be taken into account for understanding the protein structure 
and function, which includes the post-translational modification (PTM), protein-protein 
interactions (PPIs) and protein conformation. PTM can be achieved by protein 
phosphorylation, acetylation, methylation, ubiquitination or glycosylation (Krishna and 
Wold, 1993; Phizicky and Fields, 1995; Jensen, 2004). PPIs are essential for many 
biological processes including cell-cell communication, cell metabolism and 
transcriptional regulation (Braun and Gingras, 2012). Moreover, PPIs also play a role in 
forming protein complex to receive exogenous and endogenous signals and transmit 
them (Berggard et al., 2007; Yamada and Bork, 2009; Petta et al., 2015). Therefore, 
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investigating the protein interaction network has become a hotspot of proteomics 
research. So far, there are several methods developed for studying PPIs such as yeast 
two-hybrid system (Fields and Song, 1989), phage body display technology (Smith and 
Petrenko, 1997), GST pull-down assays (Smith and Johnson, 1988), co-
immunoprecipitation (co-IP) (Operana and Tukey, 2007) and tandem affinity purification 
(TAP) (Rigaut et al., 1999). Yeast two –hybrid system has a high sensitivity for 
analyzing the biologically active and instant protein-protein interaction. GST pull-down 
assays are able to identify stable protein complexes in vivo. This approach takes 
advantage of the strong affinity of glutathione-transferase tags for GSH beads, which 
leads to the isolation of GST fusion proteins and the closely associated molecules in 
the sample (Smith and Johnson, 1988). TAP is also a method to study PPIs by 
purifying target proteins with a fusion protein, TAP tag was first use to characterize 
protein complexes in 1999 (Rigaut et al., 1999). 
1.5.1 Co -immunoprecipitation (co-IP) analysis protein-protein 
interaction 
Co-immunoprecipitation is a classic and sufficiency technique to study protein 
interaction in vivo. In order to capture proteins that interact with the target protein, the 
target protein in the sample is isolated using its specific antibody, followed by the 
identification of immunoprecipitation protein complexes using the two-dimensional 
electrophoresis (2-DE), SDS-PAGE, western blot and Mass spectrometry (Phizicky and 
Fields, 1995; Lee, 2007). This assay can reveal the protein interaction in vivo under 
native condition and has been widely used in various biological systems (Golemis and 
Brent, 1992; Dobson et al., 2001; Monti et al., 2005). However, some weak or transient 
interactions may be difficult to detect without maintaining a more stable physiological 
interaction using strong wash buffers- However, less washing often leads to more non-
specific bindings and higher false positive alerts. The critical factor of a successful co-
IP experiment is to maintain the complex with suitable lysis and wash buffers (Monti et 
al., 2005). 
In order to compensate this disadvantage of co-IP, cross-linking can be combined to 
use. This step is meaning to covalently crosslinked two or more molecules within a 
close contact, which further strengthen the binding. The crosslinking is often achieved 
using chemical reagents with reactive groups, such as amine, sulfhydryl- and photo-
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reactive chemicals (Suchanek et al., 2005; Qin et al., 2011). Recently, there are many 
commercially cross linkers generated, including N-hydroxysuccinmide (NHS)-ester 
cross linker BS3, DSP; dimethyl subberimidate and formaldehyde (Uckert et al., 1983; 
Mattson et al., 1993; Gavazzi et al., 2007). It becomes critical to choose the 
appropriate crosslinkers First of all, due to the range of distance, an important factor to 
choose crosslinkers is the spacer arm length (Zhang et al., 2009). In addition, some 
crosslinkers are available to target the cell surface while the others can go through the 
membrane; therefore, the surface or intracellular proteins require different crosslinkers 
(Schweizer et al., 1982; Knoller et al., 1991). Moreover, cleavable and un-cleavable 
crosslinkers should be chosen differently depending on the variety of following analysis 
techniques (Knoller et al., 1991; Yang et al., 2012). With crosslinking, the transient and 
loose protein-protein interactions can be stabilized, captured and analyzed. 
1.5.2 Blue native polyacrylamide gel electrophoresis (BN-
PAGE) 
Blue native polyacrylamide gel electrophoresis (BN-PAGE) is another efficient method 
with high resolution to isolate multiple protein complexes (Sali et al., 2003). Unlike 
normal SDS-PAGE gel, BN-PAGE does not use any denaturing reagent. One can 
separate the protein complexes from various samples such as cell lysates (Vahsen et 
al., 2004), tissue homogenates as well as membranes (Schagger, 2001; Pfeiffer et al., 
2003) with the complex size ranged from 10 KDa to 10 MDa (Schagger et al., 1994). It 
is widely used for many purposes including native protein purification, 2D 
crystallization, and analysis of physiological protein-protein interactions (Poetsch et al., 
2000; Schagger and Pfeiffer, 2000). In principle, proteins are separated according to 
their hydrodynamic size and appear as blue bands in the BN gel. Interesting bands are 
excised and subjected for either proteomic experiments or a second SDS PAGE (Wittig 
et al., 2006). In addition, the percentage of gels used has to be taken into account 
according to the expected protein complex size. Gradient gel or many commercially gel 
systems with suitable buffers are also available now (Fiala et al., 2011). BN-PAGE has 
been widely used for many studies, such as the isolation of mitochondrial ATP 
synthase complex with size of ~600kDa from Arabidopsis by 3D BN/IEF/SDS-PAGE 
(Wittig et al., 2006). Seven merozoite surface proteins complex were also identified by 
separating detergent-resistant membrane proteins using BN-PAGE (Sanders et al., 
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2007). Often several approaches are applied for interaction studies. For instance, by 
using two-dimensional blue native/SDS-PAGE, two protein complexes were 
characterized in HepG2.2.15 cells; then by using mass spectrometry, 20% of these 
proteins were identified to be heat shock proteins, including Hsp60, Hsp70 and Hsp90. 
Furthermore, it was verified with co- immunoprecipitation assays that Hsp60, Hsp70, 
Hsp90 interacted with each other (Liu et al., 2009). 
 P. falciparum proteomics  1.6
Despite that the genome study of the P. falciparum has been completed (Gardner et 
al., 2002), a large- scale comprehensive study of its proteome is still required for 
understanding the mechanism of parasite development and survival in the host cell. 
Therefore, the large-scale quantification of protein levels during different stages of 
development can provide more insights toward understanding the extraordinarily 
complicated plasmodium and erythrocyte reorganization mechanism immune response 
of host cell (Florens et al., 2002). The dynamics of proteomic profiles during different 
stages of P. falciparum development provide further information for the interaction 
between parasites and human host cells. In addition, the improvement of Plasmodium 
proteomics study could clarify the signal pathway of the host cell under physiological 
and disease condition as well as search for potential biomarkers to establish new 
therapies strategies (Florens et al., 2002; Lasonder et al., 2002).  
So far, 2,415 parasites proteins were identified in the strain 3D7 by LC-MS/MS; as 
expected, only 6% of total proteins were found in all four stages (sporozoites, 
merozoites, trophozoites and gametocytes) such as transcription factors, ribosomal 
proteins, and cytoskeletal proteins (Lasonder et al., 2002). Sporozoite stage has the 
most abundant stage-specific proteins (nearly 50%). By analyzing the sequence of 
these proteins, 439 of them were identified with one or more transmembrane domains; 
while 309 proteins contain a signal sequence (Lasonder et al., 2002). Surface proteins 
have been found be widely expressed in different stages, indicating that these surface 
proteins may be involved in the parasite–host interactions during immune evasion 
(Lasonder et al., 2002). Through two-dimensional gel electrophoresis with LC-MS/MS, 
27 novel antigens were found to be extracellular secreted into the medium at asexual 
blood stages of P. falciparum. And half of the proteins were suggested to be involved in 
encoding parasite putative antigenic determinants (Singh et al., 2009). During invasion, 
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P. falciparum recognizes various erythrocyte surface receptors in order to switch on the 
invasion pathway. The quantitative proteomics suggested that merozoite protein levels 
have a significant change during invasion (Kuss et al., 2012). After the merozoites 
invade into new erythrocytes to start a new parasite life cycle, they develop, divide and 
modify the host cell by exporting proteins, which cross the parasite plasma membrane 
(PPM) and the parasitophorous vacuole membrane (PVM), then were secreted into the 
erythrocyte cytosol. Some of these proteins cross the erythrocyte membrane and 
locate at the surface to change the physiology of erythrocytes (Marti et al., 2004). 
Furthermore, by comparing the composition of membrane proteins of infected and non-
infected erythrocyte using two-dimension electrophoresis (2D-DIGE), over 100 proteins 
were identified over represented. Most of them were human proteins in the infected 
sample.  Surprisingly, many of these proteins are not membrane proteins and present 
in the erythrocyte cytosol under normal conditions, such as heat shock protein 70 that 
was identified in the infect red blood cell membrane as well as another chaperone 
TCP1 (Fontaine et al., 2012). The proteome expression study under life and 
physiological conditions allows us to identify proteins related to intracellular and 
intercellular signaling pathways, which may be the potential targets for establishing 
new diagnosis and therapy strategy. 
1.6.1 Protein-protein interactions studies in P. falciparum 
In general, proteins often require interaction with others to function. Although some 
progress has been made using the proteomics study for P. falciparum, the knowledge 
of protein-protein interactions remains insufficient. The first P. falciparum protein-
protein interactions (PPIs) study was made in 2005, where 2,846 potential protein-
protein interactions were identified in P. falciparum via yeast two-hybrid assays 
(LaCount et al., 2005). This was the first time where a large-scale investigation of 
protein-protein interactions has been performed to understand the interaction network 
in P. falciparum.  Investigators have also tried to study the PPIs under the physiological 
condition for fundamental biological processes. How proteins contact with each other to 
function properly during Plasmodium invasion, parasite development and the 
modification of the host cell is always a research hotpot. BN-Page has become a 
powerful technique for purifying potential protein complexes. While studying the 
merozoite surface proteins complexes, the detergent-resistant membrane proteins 
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were separated using BN-PAGE and identified by HPLC-MS/MS. There are seven 
known protein complexes, including MSP-1/7, RAP1/2 and RAP1/3, high molecular 
weight rhoptry complexes (RhopH1/H2/H3), and the invasion motor complex 
(GAP45/GAP50/myosin A) were found among 62 identification proteins (Sanders et al., 
2007). Other than BN-PAGE, co-immunoprecipitation (co-IP) has also been widely 
used. For instance, a novel translocon protein complex PTEX (PTEX150, Hsp101, 
PTEX88, EXP2, TRX2) on PVM was found using Co-IP followed by mass spectrometry 
(de Koning-Ward et al., 2009; Elsworth et al., 2014). Similarly, co-IP is also used for 
studying co-chaperones. For example, the interaction of two important chaperones 
(PfHSP70 and PfHSP90) that play a role in assisting protein folding was identified by 
co-IP as well (Gitau et al., 2012). Moreover, this approach also works for the 
purification of large molecular-weight protein complexes. One of these complexes 
contains P. falciparum WD40 -repeat protein PfWLP1 that is expressed both in 
schizonts and gametocyte stages which was found to associate with cell adhesion 
protein PfAMA1 in schizonts stage and interact with PfCCp1 and Pfs230 in 
gametocytes (von Bohl et al., 2015). 
 Mass spectrometry base proteomic analysis  1.7
1.7.1 Mass spectrometry 
Mass Spectrometry analysis is a method to identify molecules based on the mass to 
charge ratio. In general, mass spectrometry use an ion source to convert molecules 
into gas-phase ions; then a mass analyser separates ionized analytes base on the m/z 
ratio, in parallel with a detector to record the number of ions for each m/z value. As two 
types of soft ionization technologies, MALDI-MS (matrix-assisted laser 
desorption/ionization-M) and ESI-MS (electrospray ionization), have been developed, it 
is possible to analyze high polar, thermally unstable and involatile samples, especially 
peptides or proteins (Karas and Hillenkamp, 1988; Fenn et al., 1989).  MALDI-MS uses 
ions samples from dry crystalline matrix by pulsing with laser and is normally used for 
analyzing less complicated peptide mixtures, such as two-dimensional gel protein spots 
or purified proteins that are digested into peptides (Aebersold and Mann, 2003). ESI-
MS can analyze molecules without fragmentation, and can be always combined with a 
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high performance liquid chromatography (HPLC), which pre-chromatographic 
separated samples (Fenn et al., 1989). Therefore, ESI-MS can be used to analyze 
complicated mixtures, such as total protein mixtures, mixed gel bands from SDS-PAGE. 
A remarkable feature of ESI-MS is that it is suitable to work as a tandem mass 
spectrometry; this is because ESI-MS can produce multiple charged peaks that make 
charged ions break more easily, and induce ion collision by selection, in order to get 
the target peptide sequence (Ho et al., 2003) 
The mass analyzer is a core element of mass spectrometry, which determines the 
sensitivity, resolution, and accuracy of MS. The popular mass analyzers include ion 
traps (Chi et al., 2007), time-of-flight (TOF) (Loo et al., 2001), quadrupoles 
(Salamonsen et al., 1986) and Fourier transform-based instruments (FTICR) 
(Zabrouskov and Whitelegge, 2007). Recently, there is a new tandem mass 
spectrometry developed, named LTQ-Orbitrap (Thermo Fisher Scientific) (Hu et al., 
2005). It contains a LTQ with a C-trap as well as the Orbitrap. This tandem MS take the 
advantage of the high sensitive, robustness, MS/MS capability of LTQ as well as the 
high resolution and high mass accuracy of the Orbitrap, becoming one of the top 
choices to use (Macek et al., 2006; Han et al., 2008). 
1.7.2 Mass spectrometry based proteomics analysis 
 Along with mass spectrometry development, this becomes a powerful proteomic 
instrument for protein purifications as well as studying protein-protein interactions and 
protein post-translational modification. In addition, high sensitivity and resolution of 
mass spectrometry make the identification of low abundant proteins possible. 
Therefore, mass spectrometry provides the foundation for a systematic study of the 
function and dynamics of proteins in a large scale. In general, the isolation protein from 
cell and tissue by affinity purification and biochemistry extraction is normally either 
separated in one dimension gel or dissolve in the buffer, subsequently, the protein can 
be enzymatically fragmented into peptides from gel or directly in solution. The enzyme 
is used for digestion normally by trypsin, which cleaves the lysine and arginine residues 
at the carboxyl side. Normally, the mixture peptides are separated by high-pressure 
liquid chromatography (HPLC) especially by using reverse-phase HPLC before 
injection in the mass spectrometry. Peptides are separated and eluted to the 
electrospray ion source by the hydrophobic interaction intensity between the peptide 
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and hydrocarbonaceours materials, the stronger interaction, the longer of peptides 
retention time in the column (Meek, 1980). Followed, protonated peptide enters to the 
mass spectrometry, and the mass to charge ration (precursor ions) of the peptide 
eluting is taken immediately at the first mass spectrometry (MS1). At the second mass 
spectrometry, the precursor ions are fragmented by the collision-induced dissociation 
(CID) in to product ions and MS/MS spectra are taken and searched against the protein 
sequence database (Han et al., 2008) (Figure 1.5) 
 
 
Figure 1.5: proteomics analysis basic strategy. (Aebersold and Mann, 2003) 
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 Objective 1.8
Over 400 parasite-encoded proteins are predicted to be exported to the infected red 
cell cytosol by Plasmodium falciparum and involved in modify the host cell including 
cytoadhesive and permeability for their own survival. During the transport, parasite 
exported protein need to cross the plasma membrane of the parasite (PPM) and the 
parasitophorous vacuole membrane (PVM) to the infected erythrocyte cytosol sites, 
and further deliver to the surface of red blood cell membrane to alter the morphology, 
physiology and function of red blood cell membrane. Exported parasite proteins are 
also involved in inducing new membrane structure in parasite infected erythrocyte 
cytosol such as Maurer’s clefts and tubulovesicular network (Maier et al., 2009). 
Recently, Our group found a novel highly mobile structure in the infected erythrocyte 
cytosol referred to as J-dots, which were contained members of exported co-
chaperones Hsp40s (PFE55, PFA660) (Kulzer et al., 2010). Subsequently, we could 
also identify a parasite-encoded exported Hsp70 (PfHsp70x) in complex with PFE55 at 
the J-dots (Kulzer et al., 2012). The aim of our work is to further understand the 
importance of this structure for parasite protein trafficking and parasite survival in the 
red blood cell. Therefore multiple proteomics methods will be used to purify and 
characterize of the entire proteome of the J-dots, and further address out the potential 
functional of J-dots by study protein-protein interaction between PFE55/PfHsp70x and 
other protein candidates. 
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2 MATERIALS AND METHOD  
 Materials and Chemicals 2.1
2.1.1 Appliances 
 
Appliances  Company Company 
headquarters 
Autoclave Thermo Scientific USA 
Blotting apparatus  Phase Lübeck 
Centrifuge (5804R)  Eppendorf Hamburg 
Electroporator (gene 
PulserII) 
Bio-Rad USA 
Glass slides IDL Italy 
LTQ-Orbitrap Elite Mass 
spectrometry 
Thermo Fisher USA 
Nano-LC UltiMate 3000 Thermo Fisher USA 
pH meter Bio-Rad München 
Thermoblock Heidolph Schwabach 
Thermomixer 5436 Eppendorf Hamburg 
Vortexer (Reax 2000) Heidolph Schwabach 
Weighing machine (1205) Sartorius Germany 
Weighing machine (P1200) Mettler Toledo  
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2.1.2 Materials  
Appliances  Company Company headquarters 
Centrifuge tubes Eppendorf Hamburg 
Culture flasks (25 cm2 and 
75 cm2) 
Greiner Frickenhausen 
Falcon tubes Greiner Frickenhausen 
Pipette tips Sarstedt/Greiner Nümbrecht/Frickenhausen 
Plastic material Sarstedt//Greiner Nümbrecht/Frickenhausen 
Whatman paper Schleicher & 
Schuell 
Dassel 
Gel loader tips VWR Darmstadt 
 
2.1.3 Chemicals 
Chemicals Company Company headquarters 
0.1% Trifluoroacetic Fluka Neu-Ulm 
1,4-dithio-DL-threitol (DTT) Fluka Neu-Ulm 
10% Dodecylmaltoside (DDM) Thermo Fisher USA 
Acetonitrile (HPLC grade) Fluka Neu-Ulm 
Ammonium peroxodisulfate (APS) Roth Karlsruhe 
Ammonium sulfate ((NH4)2SO4) Roth Karlsruhe 
Comassie Brilliant Blue AppliChem Darmstadt 
Dimethylsulfoxide (DMSO) Fluka Neu-Ulm 
Dipotassium phosphate (K2HPO4) Roth Karlsruhe 
Disodium phosphate (Na2HPO4) Roth Karlsruhe 
DSP (dithiobis(succinimidyl Thermo Fisher USA 
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propionate)) 
Glycerol anhydrous AppliChem Darmstadt 
Glycine Roth Karlsruhe 
Iodoacetamide (IAA) Sigma USA 
Isopropanol Merck Darmstadt 
Luminol AppliChem Darmstadt 
Method Roth Karlsruhe 
N,N,N',N'-tetramethylethane-1,2-
diamine 
Roth Karlsruhe 
Phenylmethylsulfonyl fluoride 
(PMSF) 
Serva Heidelberg 
Potassium dihydrogen phosphate 
(KH2PO4) 
Roth Karlsruhe 
Protease Inhibitor Cocktail Set III Calbiochem USA 
Proteinase K AppliChem Darmstadt 
Protein Prestained Ladder Thermo Fisher USA 
Rotiphorese Gel 30 Roth Karlsruhe 
Sodium dodecyl-phosphate (SDS) AppliChem Darmstadt 
Streptolysin O S.Bhakdi  
Tris AppliChem Darmstadt 
Triton X-100 Roth Karlsruhe 
Trypsin Promega USA 
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2.1.4 Cell Culture Materials 
Cell culture materials Company Company headquarters 
AlbuMaxII Invitrogen Groningen 
D-Sorbitol Roth Karlsruhe 
Gelafundin B. Braun AG Melsungen 
Giemsa Merck Darmstadt 
Human erythrocyte 
concentrate (A/rh+) 
University medical 
centre 
Marburg, 
Bloodbank 
Marburg 
Human Plasma (A/rh+) University medical centre 
Marburg/Giessen, 
Bloodbank 
Marburg 
Hypoxanthine PAA Cölbe 
RPMI 1640 Gibco Karlsruhe 
WR 99210 Jacobus 
Pharmaceuticals 
USA 
 
 
2.1.5 Molecular Biology Kit 
Molecular Kits Company Company 
headquarters 
Pierce Co-Immunoprecipitation 
Kit 
Thermo Fisher 
Scientific 
USA 
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2.1.6 Antibody 
 
 
 
 
Primary Antibody 
 
Dilution 
Factor 
 (IFA) 
Dilution 
Factor  
(Wester
n 
blotting
) 
 Original 
Mouse anti-GFP (monoclonal) 1:100 1:500 Abcam 
Mouse anti-Glycophrin A/B 
(monoclonal) 
--- 1:1000 Abcam 
Mouse anti-human Hsp70 
(monoclonal) 
--- 1:500 Santa Cruz 
Biotechnology 
Mouse anti-PfGBP130 
(monoclonal) 
1:1000 1: 1500 Group Holder 
Mouse anti-
PfHsp101(monoclonal) 
1:1500 1:1000 Group Holder 
Rabbit anti-PfSBP1 (monoclonal) 1:1000 1:500 Group Przyborski 
Rabbit anti-PfAldolase 
(polyclonal) 
--- 1:5000 Group Przyborski 
Rabbit anti-PfExp1 (monoclonal) --- 1:500 Group Przyborski 
Rabbit anti-PfGBP130 
(monoclonal) 
--- 1:500 Group Przyborski 
Rabbit anti-PfHsp70x (polyclonal) 1:100 1:500 Group Przyborski 
Rabbit anti-PfPhistC(monoclonal)                    1:1500 1:1500 Group Holder 
Rabbit anti-PfSBP (monoclonal) 1:1000 1:500 Group Przyborski 
Rabbit anti-PfSERP (polyclonal) --- 1:1000 Group Przyborski 
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Secondary antibody Dilution Company Company 
Headquarter 
Goat anti-mouse HRP 1:2000 DAKO Glostrup 
Goat anti-rabbit HRP 1:2000 DAKO Glostrup 
Goat anti-chicken Cy2 1:2000 JacksonImmunso Research 
Laboratories 
USA 
Goat anti-mouse Cy3 1:2000 JacksonImmunso Research 
Laboratories 
USA 
Goat anti-rabbit Cy3 1:2000 JacksonImmunso Research 
Laboratories 
USA 
2.1.7 Solutions and buffers 
Solutions and buffers used for molecular and biochemical work are listed. 
Solutions and buffers Individual components 
Sample buffer (2x) for proteins 100 mM Tris/HCl pH 6.8 
5 mM EDTA 
20 % glycerol 
4 % SDS 
0.2 % bromphenolblue 
100 mM dithiothreitol 
Separating buffer (4x) 1.5 M Tris/HCl pH 8.8 
Stacking buffer (4x) 500 mM Tris/HCl pH 6.8 0.4 % SDS 
Sample buffer (2x) for proteins 100 mM Tris/HCl pH 6.8 
5 mM EDTA 
20 % glycerol 
4 % SDS 
0.2 % bromphenolblue 
100 mM dithiothreitol 
Western blot transfer buffer 48 mM Tris/HCl pH 9.5 
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39 mM glycine 
0.04 % SDS 
20 % methanol 
Phosphate buffered saline (PBS) 140 mM sodium chloride (NaCl) 
2.7 mM potassium chloride (KCl) 
1.4 mM monopotassium phosphate 
0.8 mM disodium phosphate 
Electrophoresis running buffer 124 mM Tris 
960 mM glycine 
0.05 % SDS 
Blocking solution for IFA 3 % BSA in PBS (pH 7.4) 
BN sample buffer  20mM bis-tris 
500mM 6-aminocaproic acid 
20mM NaCl  
2mM PH 8.0 EDTA 
10% Glycerol 
PH 7.0 
0.01% coomassie Brilliant G-250 
3x BN-Gel Buffer 
 
Bis-tris 150mM 
ε-aminocaproic acid 200mM 
Solutions used for culturing P. falciparum are listed as following: 
Solutions  Individual components 
RPMI medium 500 ml RPMI medium supplemented with 
50 ml of heat-activated human plasma 
50 mg neomycin 
200 µM hypoxanthine 
Freezing solution 28 % glycerol 
3 % d-sorbitol 
0.65 % sodium chloride 
Thawing solution 12 % sodium choride (NaCl) 
1.6 % sodium chloride (NaCl) 
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0.9 % sodium chloride, 0.2 % glucose 
WR99210 20 mM stock (8.6 mg in 1ml DMSO) working 
concentration: 5 nM 
2.1.8 Cells strains 
Strain Reference 
P. falciparum strain 3D7 The Walter and Eliza Institute of Medical 
Research, Melbourne, Australia 
P. falciparum PFE55GFP Simone Külzer, et al., 2010 
P. falciparum PFA660GFP Simone Külzer, et al., 2010 
 
 Methods 2.2
2.2.1 Cultivation of P. falciparum 
The asexual stages of P. falciparum were cultivated in RPMI medium containing 4% 
hematocrit A+ human erythrocytes, 0.2 % hypoxanthine, 10 % human plasma and 
0.1mg/ml neomycin in the suspension culture flasks. The parasites were incubated at 
37 °C and supplied with gas containing 90 % N2, 5 % O2 and 5 % CO2. Every 24h the 
medium was changed with a glass pipette without disturb the cells. The parasitemia 
was checked with Giemsa stain solution:  ~5ul of blood drops were taken from the 
bottom of the flask onto a glass slide; after the smear was dry, we fixed the slide in 
Methanol for 30s and stained it with Giemsa solution (1:10 diluted with H2O) for 5-10 
min. Next, we washed off the excess staining solution and examined the slide with light 
microscope at a hundred-fold magnification. 
2.2.2 Parasites synchronization 
The whole cycle of P. falciparum mainly consists of four stages: ring, trophozoite, 
schizont and merozoite stages. In this study, most of the work was performed on 
parasites during the thophozoite stage. In order to get more synchrony parasites and 
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high parasitemia, parasites during ring stage were synchronized using 5% of sorbitol 
solution (Lambros and Vanderberg, 1979) ; while at trophozoites stage, parasites were 
enriched by gelafundin flotation (Pasvol et al., 1978). 
Synchronization of P. falciparum with sorbitol: 
Cultures were transferred into a falcon tube and centrifuged at 3000 rpm for 2 min; the 
pellet was then resuspended in 5 times volume of pre-warm sorbitol solution (5%). 
After incubating the mixture in water bath for 10-12 min at 37 °C, we centrifuged the 
mixture at 3000 rpm for 2 min, followed by washing the pellet twice with 10 times 
volume of medium. In order to get more synchronized parasites, the parasites can be 
treated with sorbitol again after 4 hours. 
Trophozoite-stage parasites enrichment via gelafundin flotation: 
Cells were collected by centrifugation at 3000 rpm for 2 min and resuspended with 10 
ml of pre-warmed gelafundin flotation buffer. The mixture was then incubated in water 
bath for 12 min at 37 °C. During the incubation, knob-associated cells floated into the 
upper phase of the gelafundin cell mixture; while most of non-infected and ring-stage 
parasites were found at the bottom. The upper phase was collected and centrifuged at 
3000 rpm for 2 min to obtain trophozoite-infected cells. Cells were suspended in 10 
times volume of medium for further use.  
2.2.3 Freezing and thawing of P. falciparum 
Freezing P. falciparum: 
Ring-stage parasites were transferred with 5%-10% parasitemia culture into a falcon 
tube, centrifuged at 3000 rpm for 2min; the resulting pellet was resuspended with 
freezing solution. The resuspension was then transferred into the freezing tube and 
kept in the liquid nitrogen for long-term preservation. 
Thawing P. falciparum: 
First of all, we pre-warmed all the solutions. Frozen cells stored in the liquid nitrogen 
were then thawn for several minutes in the flow at room temperature. Cells were then 
transferred from the freezing tube to a falcon tube; 200-250 ul of 12% NaCl solution 
was then added drop by drop into cells and gently mixed. After incubation for 3 min, 5 
ml of 1.6% NaCl solution was added into the mixture slowly and incubated for another 
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3 min. Finally, 5 ml of 0.9% NaCl solution was also added followed with 3-min 
incubation time. Cells were collected by centrifugation at 3000 rpm for 2 min and 
washed with 10 ml of RPMI medium before further use. 
2.2.4 SLO (Streptolysine O) permeabilization of P. falciparum-
infected erythrocytes 
SLO (streptolysine O) is a membrane damage toxin secreted by Streptococcus 
pyogenes. SLO can permeabilize the host red blood cell membrane while leave the PV 
(parasitophorous vacuole) intact by binding to surface exposed membrane cholesterol 
induce a 30nm hole on the membrane (Bhakdi et al., 1985; Jackson et al., 2007). The 
SLO treatment assay is used to analyze the subcellular localization of protein 
complexes in plasmodium-infected red blood cells in this study. 
2 x 108 of trophozoite-stage parasite-infected red blood cells were treated with 3 
hemolytic units (HU) of SLO in 188 µl of PBS (pH 7.4) and incubated for 6 minutes at 
room temperature while gently mixed every 2 minutes, followed by centrifugation at 
1,000 x g for 3 minutes. The supernatant was transferred into a new 1.5 ml tube while 
the pellet was washed two more times with PBS supplemented with 1mM PMSF and 
protease inhibitor cocktail (Knoller et al.) (1:200 dilution).The supernatant and pellet 
were either used for western blotting or co-immunoprecipitation (co-IP) assays. 
2.2.5 Saponin lysis of Plasmodium falciparum-infected 
erythrocytes 
Saponin is a glycoside, which is commonly found in plants and known to disintegrate 
the erythrocyte membrane and the parasitophorous vacuolar membrane of P. 
falciparum but leaves the parasite interacting with cell membrane cholesterol, leading 
to the permeabilization of the membrane (Beaumelle et al., 1987). In this study, 
saponin lysis was also used to analyze the subcellular localization of protein complexes 
in plasmodium-infected red blood cells. 
The trophozoite-stage infected erythrocytes were enriched with gelafundin flotation. A 
total of 2 x 108 cells were treated with 0.02 % saponin dissolved in PBS (pH 7.4) 
supplemented with 1 mM PMSF. The cells were incubated for 10 min on ice while 
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gently mixed, followed by the centrifugation at 5000 rpm for 5 minutes at 4 °C. The 
supernatant was then transferred into a new 1.5 ml tube; while the pellet was washed 
for two and more times with PBS (pH 7.4) supplemented with 1 mM PMSF and PIC 
(1:200 diluted). The supernatant and pellet were used for either western blotting or co-
IP assay. 
2.2.6 Protease K protection assay 
In this study, protease K protection assay was used to analyze the subcellular 
localization of protein complexes in P. falciparum infected red blood cells. 
The trophozoite-stage parasites were treated either with 0.02 % saponin or SLO (3 
HU); afterwards, the pellet fraction was collected and mixed with 0.5 µl of 10 mg/ml 
protease K diluted in PBS. After 30 min incubation time on ice, 2 mM PMSF and PIC 
(1:100 diluted) was added into cells in order to inactivate Protease K activities. The 
pellet was then collected by centrifugation at 13,200 g for 30 s, and then washed with 
PBS for two or more times. The pellet was used for either western blotting or co-IP 
assay. 
2.2.7 Differential ultracentrifugation 
Differential centrifugation is a centrifuge optimized at different speeds to separate the 
organelles from whole cell lysate according to the size and density. Here, this method 
was performed to isolate the J-dot fraction.  
The trophozoite-stage P. falciparum-infected red blood cell were lysed by 5mM 
Na2HPO4 buffer containing PIC (1:100 diluted) and 1 mM PMSF, followed by the 
ultracentrifugation at 4°C with following steps: 5000 g for 10min, 10,000 g for 10min, 
20,000 g for 10min, 33,000 g for 30min, 80,000 g for 1 hour, and 100,000 g for 2 hour. 
The pellet was then washed for twice with lysis buffer with the above centrifugation 
protocol. Finally, the pellet was dissolved in 2 x SDS sample buffer supplemented with 
100mM DTT, and analyzed by immunoblot assays.  Antibodies used included 
monoclonal mouse anti-GFP (1:1000 diluted), polyclonal rabbit anti-PfHsp70x (1:500 
diluted), monoclonal rabbit anti-PfSERP (1:1000 diluted), monoclonal rabbit anti-
PfAldolase (1:5000 diluted), monoclonal rabbit anti-PfSBP (1:500 diluted), monoclonal 
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rabbit anti-PfExp (1:500 diluted), and monoclonal mouse anti-Glycophrin A/B (1:1000 
diluted). 
2.2.8 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is used to 
separate proteins according to their molecular weights (Laemmli, 1970). The sodium 
dodecyl sulfate (SDS) is an anionic detergent that linearizes proteins by disturbing the 
3-dimensional structure of proteins. Proteins migrate from the negative-charged to 
positive-charged side and get separated in the polyacrylamide gel according to their 
molecular weights. As for further denaturation, some additional reducing reagents can 
be used, such as dithiothreitol (DTT) or 2-mercaptoethanol (beta-
mercaptoethanol/BME).  
In this study, samples for SLO, saponin permeabilization, ultracentrifugation and co-IP 
were resuspended in 2 x SDS loading buffer containing 100mM DTT and boiled at 100 
°C for 10 minutes. The denatured protein samples were separated in a 12 % SDS-
PAGE gel (Table 2.1). The running voltage was initially set up at 90 V before protein 
entered into separate gel from stacking gel, then the voltage was increased to 120 V 
until finished and a pre-strain protein ladder was used to determine protein molecular 
weight. The SDS-PAGE gel was either stained with coomassie brilliant blue buffer 
containing 20 % methanol or subjected for the western blotting assay. 
 
Table 2.1: SDS-PAGE. 
Reagent 4% Stacking gel (ml) 12% Separating gel (ml)  
ddH2O 
Gel Buffer               
30 % acrylamide 
2.56 
1.875 
3 
3.1 
1.25 
0.65 
APS 
TEMED 
0.05 
0.005 
0.025 
0.005 
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2.2.9 Western blotting 
After electrophoresis, the protein can be transferred to PVDF (polyvinylidene fluoride) 
or nitrocellulose membrane from SDS-PAGE gel for immunoblot analysis (Towbin et al., 
1979). In this study, all the western blotting was performed by a semi-dry system. Six 
pieces of Whatman paper and a PVDF membrane were prepared according to the gel 
size, and wetted with transfer buffer. The membrane was placed on the polyacrylamide 
gel and made it like a ‘sandwiched’positioned between 3 pieces of Whatman paper on 
either side; then this ‘sandwich’ was placed in a blotting chamber. The whole transfer 
was carried out at 1-2mA/cm2 for 1.5 hours allowing protein transfer to occur from 
negative-charged to positive-charge end. After the transfer finished, for checking the 
efficiency of the transfer, the membrane was stained with Ponceau S solution for 5-10 
min until protein bands were visible. Afterwards, the Ponceau S solution was washed 
out with ddH2O before proceed the immunoblot detection. Briefly, the membrane was 
blocked with 5% of the milk solution for 1 hour at room temperature with gentle 
agitation, and then washed with PBS (pH 7.4) for 3 times (10 min each) at room 
temperature, in order to remove the non-specific binding of antibodies. After washing, 
the membrane was incubated with primary antibody diluted in 5% of milk solution 
overnight at 4 °C with gently shaking. The next day, the membrane was washed for 3 
times with PBS (pH 7.4), and incubated with the secondary antibody conjugated to 
Horseradish Peroxidase (HRP) (1:2000 diluted in 5% of milk solution) for 2 hours at 
room temperature with gently shaking. After incubation, the membrane was washed for 
3 times with PBS (pH 7.4). The detection was carried out using the Enhanced 
Chemiluminescence (ECL) detection system. The membrane was incubated with a 
luminol, which is a substrate reacting with the conjugated secondary antibody to 
produce the light signal. The chemiluminescence can be captured on X-ray film. 
2.2.10 Blue native polyacrylamide gel electrophoresis (BN-
PAGE) 
Blue native polyacrylamide gel (BN-PAGE) is used to separate protein complexes as 
well as identify physiological protein–protein interactions (PPIs) and subunit 
composition of protein complexes without denaturing proteins. BN-PAGE provides a 
higher resolution than gel filtration or sucrose density ultracentrifugation. In BN-PAGE, 
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protein complexes were separated according to the hydrodynamic size and structure in 
the polyacrylamide matrix. In this study, BN-PAGE was used for separating the multiple 
complexes in P. falciparum-infected erythrocytes.  
The trophozoite-stage P. falciparum-infected red blood cells were enriched by 
gelafundin flotation and lysed with 5mM Na2HPO4. After ultracentrifugation with 800000 
g force, the pellet was dissolved in blue native sample buffer (20mM bis-tris, 500mM 6-
aminocaproic acid, 20mM NaCl, 2mM PH 8.0 EDTA, 10% Glycerol, PH 7.0) containing 
0.5% of dodecylmaltoside and 0.01% of coomassie Brilliant G-250. The electrophoresis 
was performed in the 4 % stacking gel followed by 4%-15% gradient separating gel 
(Table 2.2). The voltage setup was 100V for running within the stacking gel and 180V 
while running in the gradient separating gel. HMW Native marker was used as a 
standard (GE Healthcare). The aminocaproic acid was used for improving the 
solubilization of membrane proteins; while Blue G induced a charge shift on the 
constituent proteins (Van Coster et al., 2001). 
 
Table 2.2: BN-PAGE. 
  
2.2.11 Western blotting of two dimension BN /SDS –PAGE  
In the first dimension of BN-PAGE, proteins complexes were separated without 
destroying the protein-protein interaction under a native condition; while the protein 
subunits from the one protein were separated in a secondary SDS-PAGE. In this study, 
this method was used for analyzing the multiple complexes from parasite infect red 
Reagent 3.2% Stacking gel 
(ml)  
4% Separating gel 
(ml) 
15% Separating gel 
(ml)  
ddH2O 
3 x BN buffer             
30 % acrylamide 
5.04 
3.00 
0.96 
4.5 
2.5 
1 
1.25 
2.5 
3.7 
APS 
TEMED 
0.12 
0.012 
0.054 
0.0054 
0.042 
0.0042 
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blood cell. 
 Once the first dimension of BN-PAGE gel was finished, the lane with protein samples 
was sliced and boiled in 2 x SDS sample buffer containing 100mM DTT for 20 s, 
followed by the incubation for 0.5 hour at room temperature with gentle shaking. For 
the second dimension, the denatured sample was separated in a 10% of 18x20 cm 
SDS-PAGE running at room temperature with a voltage at 100 V for stacking gel and 
160V for separating gel, respectively. The secondary SDS-PAGE was followed by 
either immunoblot detection or LC/MS/MS identification (Figure 2.1). Antibodies used in 
this section were listed as following: monoclonal mouse anti-GFP (1: 1000 diluted), 
polyclonal rabbit anti-PfHsp70x (1:500 diluted), polyclonal rabbit anti-PfPHISTC (1: 
1000 diluted), and polyclonal rabbit anti-PfGBP130 (1: 1000 diluted). 
 
 
 
 
Figure 2.1: Two-dimension BN/SDS-PAGE analyses of the cellular lysates.  
Multiple protein complexes were purified by ultracentrifugation, followed by BN-PAGE. The protein 
complexes were either analyzed with LC-MS/MS or a second dimension SDS-PAGE. The components of 
multiple protein complexes can be verified by either immunoblot analysis or LC-MS/MS. 
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2.2.12 In-vivo cross-linking 
Cross-linking is a bond active links from one polymer chain (protein) to the other. It has 
been widely used in protein chemistry study especially in protein-protein interactions 
(PPIs) research because cross-link would help to binding the week and instantaneous 
interaction between proteins in vivo. By using chemical reagents with reactive groups, 
like amnie, sulfhydryl- and photo-reactive, formed the cross-link and they are mostly 
used in protein crosslinking. Recently, there are many commercially cross linkers have 
been generated such as N-hydroxysuccinmide (NHS)-ester cross linker BS3 
(bis(sulfosuccinimidyl)suberate), DSP (dithiobis(succinimidyl propionate)), dimethyl 
subberimidate and formaldehyde (Uckert et al., 1983; Mattson et al., 1993; Gavazzi et 
al., 2007). In this study, DSP was used for crosslinking, since it is lipophilic and 
membrane–permeable and useful for intracellular and intramembranous conjugation. 
The trophozoite-stage P. falciparum infected red blood cell were enriched by gelafundin 
flotation as described above, washed two times by PBS (PH 7.2) reaction buffer, 
followed by cross-linking with 1.5mM DSP on ice for 2 hour. The reaction was then 
terminated by15mM Tris-HCl (PH 7.5) at room temperature for 15 min. Afterwards, 
cells were washed with PBS (PH 7.2) for 3 times, and ready for the further co-
immunoprecipitation assays. 
2.2.13 Co- immunoprecipitation (co-IP) 
Co-immunoprecipitation (co-IP) is a technique to identify relevant protein-protein 
interactions (PPIs) by using target protein-specific antibodies to indirectly capture 
proteins that bind to the target protein. This approach is often used to identify new 
interaction partners of the target protein followed by two dimensional electrophoresis 
(2-DE), SDS-PAGE and Mass spectrometry (Figure 2.2) (Phizicky and Fields, 1995; 
Lee, 2007). 
In this section, trophozoite-stage parasites were enriched by gelafundin flotation as 
mentioned above followed by crosslinking with 1.5mM DSP on ice for 2h. The reaction 
was terminated by incubation with 15mM Tris-HCl at room temperature for 15 min. The 
crosslinked cells were lysed with lysis buffer containing PIC (1:200 diluted) and 1 mM 
PMSF, and centrifuged at 1300 g, 4 °C for 10 min to remove cell debris. The 
supernatant of the lysis was used for co-IP (IP, Pierce co- immunoprecipitation kit, 
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Thermo Scientific, Rockford, IL, USA). Antibody beads needed were generated as 
describe The AminoLink Plus Coupling Resin and reagents were equilibrated at room 
temperature. The 20x couple buffer was diluted to 1 x. Next, 50µl of resins were added 
into the column and centrifuged at 3000 rpm for 1 min, followed by washing for twice 
with 1X coupling buffer. Gently tapped the bottom of the spin column on a paper towel 
to remove the excess liquid and inserted the bottom plug. 5-10 µg of antibodies were 
used for coupling by adjusted the volume to 200 µl with PBS and 3 µl of Sodium 
Cyanoborohydride Solution. The antibody solution and beads were incubated for 90-
120 min with gentle agitation at room temperature. And then the flow was collected for 
the further analysis by centrifugation. The coupling reaction was terminated by 
incubating with 200 µl of quenching buffer at room temperature for 15 min. After that, 
the antibody-resin was washed for twice with 1X coupling buffer, followed by washing 
with 150 µl of wash buffer for 6 times. The antibodies used for generating antibody-
bound beads were as following: monoclonal mouse anti-GFP, polyclonal rabbit anti-
PfHsp70x, monoclonal mouse anti-PfHsp101 and polyclonal rabbit anti-PfGBP130. For 
immunoprecipitation, after pre-incubating the lysate the empty agarose resin at 4°C for 
1h, the lysate was collected and mixed with the antibody-coupled resins overnight with 
gentle agitation at 4°C.  The next day, after collecting the remaining lysate, the 
antibody-protein-coupled resin was washed for two or more times to remove 
nonspecific binding proteins. The Proteins that were specifically bound to the antibody-
coupled resins were eluted using 0.1% TFA, and further analyzed by both western 
blotting and LC-MS/MS. 
2.2.14 Trypsin in gel digestion 
In gel digestion is an important step when preparing the peptide samples for mass 
spectrometric identification (Rosenfeld et al., 1992). After separated by 1D or 2D-
PAGE, protein bands were visualized by coomassie staining. The interest bands or 
spots were excised and destained for further protein digestion. The trypsin enzyme is 
widely used for protein digestion by cleaving peptide chains at carboxyl side of lysine 
and arginine.   
In this study, gel slices were washed by milli-Q water and sliced into 1mm3 pieces with 
incubating in 25 mM NH4CO3 with vortexing for 20 min for several times until the 
NH4CO3 solution was clean, moreover the gel piece was distained with 25 mM 
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NH4CO3/CH3CN 1:1 for 20 min, repeated this step until the color completely gone. 
Threw the supernatant and covered the gel piece with acetonitrile until the gel piece 
shrank. Removed the extra acetonitrile, gel particles were dried by centrifugation under 
vacuum at room temperature for 30 min. Proteins were reduced by covering the gel 
particle with 25 mM NH4CO3 containing 10 mM DTT for 1 hour at 56 °C, followed by 
alkylation of proteins by the addition of 25 mM NH4CO3 containing 55 mM 
iodoacetamide for 45 min in the dark at room temperature. Gel pieces were then 
washed with 25 mM NH4CO3 and subsequently 25 mM NH4CO3/CH3CN 1:1 for 20 min 
each. Finally, the gel was covered with acetonitrile until shranking and then dried by 
centrifugation under vacuum. In-gel digestion was performed by adding 10 ng/µl of 
trypsin dissolved in 25 mM NH4CO3 at 37 °C overnight. The next day, peptides was 
extracted from the gel by adding 2 times gel volumes of 50% CH3CN/0.1%TFA solution 
and mixed by vortexing for 20 min. All of the peptide solution was collected and dried in 
vacuum at room temperature. 
2.2.15 LC-MS/MS identification and data analysis 
LC-MS/MS is a technique combines a high performance liquid chromatography (HPLC) 
that pre-chromatographic separation samples with mass spectrometry (MS). Here, 
digested peptides were concentrated and further analyzed by LTQ-Orbitrap Elite Mass 
spectrometry (Thermo Fisher) equipped an EASY-Spray source and a nano-LC 
UltiMate 3000 high-performance liquid chromatography system (Thermo Fisher). A full-
scan survey MS experiment (m/z range from 375 to 1600; automatic gain control 
target, 1,000,000 ions; resolution at 400 m/z, 60,000; maximum ion accumulation time, 
50 ms) was performed using the Orbitrap mass spectrometer, where ten most intense 
ions were selected and fragmented by collision-induced dissociation (CID). Raw data 
were converted to mgf files by Proteome Discoverer 1.3 (Thermo fisher) and analyzed 
using pFind 2.1 software to search against the human Uniprot TrEMBL database 
(release on April 2012, human, 65,493 entries) and P. falciparum DB database (release 
on October 2013, plasmodium 3D7), respectively (Li et al., 2005). The modification was 
set as following: static modification of carbamidomethyl (Cys), dynamic modification of 
deamination (Asn), oxidation (Van Coster et al.), and acetylation (Lys). Trypsin was 
selected as the enzyme; while two missed cleavages were allowed. The mass 
tolerance was set to 20 ppm for the precursor ions and 0.5 Da for the fragment ions. A 
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false discovery rate (FDR) of 1% was estimated and applied to all data sets at the total 
peptide levels.  
2.2.16 Live cell imaging 
Cells were harvested by centrifugation, followed by washing for 3 times with RPMI 
medium. Cells were stained with 10 µg/ml Nuclear DNA Hoechse dye and incubated at 
room temperature with gentle shaking for 10 min; After a blood-drop applying to the 
slide, samples were visualized using Zeiss Axio Observer inverse epifluorescence 
microscope system at room temperature.  
2.2.17 Immunofluorescence assays 
Immunofluorescence assays were performed using acetone/methanol (90%/10%) 
fixation. 5-8µl of P. falciparum-infected and non-infected red blood cell mixture were 
taken from the culture and applied to the slide; the smear of cells was then dried and 
fixed with pre-cooled acetone/methanol (90%/10%) solution at -20 °C for 10 min. After 
the smear was completely dry, samples were blocked with 3 % BSA in PBS for 1 hour 
at room temperature. For the primary antibody incubation, the antibody was diluted in 3 
% BSA in PBS and applied onto the smear followed by the overnight incubation at 4 
°C. The next day, the slide was washed with PBS (PH 7.4) for 3 times (10 min each) to 
remove non-binding primary antibody and incubated with the secondary antibody for 2 
hours at room temperature. The slide was then washed with PBS (PH 7.4) for 3 times. 
To visualize the nuclear DNA of the fixed parasites, samples were stained with Hoechst 
33258 (50 ng/ml) for 10 min prior to visualization by epifluorescence microscopy. The 
primary antibodies used in this assay include polyclonal rabbit anti-PfHsp70x (1:2000 
diluted), monoclonal mouse anti-GFP (1:500 diluted), monoclonal mouse anti-
PfGBP130 (1:1000 diluted), monoclonal mouse anti-PfHsp101 (1:500 diluted), and 
polyclonal rabbit anti-PfPhistC (1:1000 diluted). The conjugated secondary antibodies 
include anti-rabbit-Cy2, anti-rabbit-Cy3, and anti-mouse-Cy3 (Dianova, 1:2000 diluted). 
Images were acquired using a Zeiss Axio Observer inverse epifluorescence 
microscope system, with appropriate filter sets.  
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 Bioinformatics analysis 2.3
2.3.1 Mass spectrometry data analysis 
Raw data were analyzed as mentioned in 1.2.11. The more details of databases used 
were shown in Table 2.3.  
Table 2.3: Protein database information. 
Protein database Website 
Plasmodium DB http://plasmodb.org/plasmo/ 
Uniprot http://www.uniprot.org 
GeneDB http://www.genedb.org/Homepage 
ExPASy http://www.expasy.org/ 
  
2.3.2 Image processing with Image J 
In this study, microscopic images were analyzed using ImageJ, which is an open 
source with Java-written program (http://rsbweb.nih.gov/ij/). Images were taken with the 
aforementioned epifluorescence microscope and imported into ImageJ64. The 
channels were spited into separate windows and converted into 8-bit grayscale mode. 
Every image was subjected to background subtraction. The RGB channels were split 
into red, green and blue channels before the individual images were merged. All 
images were adjusted with the brightness/contrast tool before saved as TIF files.  
 
 
 
 
 
 
 
 
 
Results 
 41 
3 RESULTS 
In previous studies, our group discovered two members of parasite-encoded type II 
Hsp40s family (PEF55, PFA660) that forming highly mobile structures in the parasite-
infected red blood cell, which was referred as J-dots. Furthermore, PfHsp70x was 
identified to partially co-localize with J-dots by immunocolocalization and 
immunoprecipitation. This observation indicates that J-dots are involved in protein 
transport through the erythrocyte. In this current study, multiple proteomics approaches 
were used to characterize the parasite-induced intra-erythrocytic protein complex and 
further construct a protein-protein interactions network in the P. falciparum infected red 
blood cell, which will expand our understanding their importance in parasite survival 
and virulence.  
 Isolation of J-dots fraction by differential 3.1
centrifugation 
In our studies, mainly work was performed on PFE55GFP transfection parasite line, 
which expresses full-length PFE55 fused to GFP, on the basis of 3D7 strain (Kulzer et 
al., 2010).  
In this section, PFE55GFP parasites infected red blood cells were subjected to 
hypotonically lysis, which was followed by a differential centrifugation. During the 
differential centrifugation protein contaminations were removed and in the end pure J-
dot fractions were obtained.  
The pellets from 1000 g-10x104 g fractions were investigated for the purification 
efficiency by immunoblots with several antibodies including checked for the purification 
efficiency by immunoblots with antibodies including anti-GFP (J-dots), anti-PfHsp70x 
(J-dots), anti-PfSERP (soluble protein of parasitophorous vacuole), anti-PfSBP1 (a 
protein marker of Maurer’s clefts), anti-PfAldolase (soluble protein of parasite cytosol), 
anti-PfEXP1 (protein marker of parasitophorous vacuole membrane (PVM)) and anti-
Glycophorin A/B (a protein marker of erythrocyte plasma membrane). As shown 
(Figure 3.1), strong signals were detected by using anti-GFP, anti-PfHsp70x, anti-
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PfSERP or anti-PfAldolase for immunoblots with samples from this fraction. This 
indicated that the signal came from from the non-lysed cell.  
Since PfSBP1 and PfEXP1 were mostly present in 5000 g, 10,000 g, 20,000 g, 30,000 
g pellets which indicates that these fractions contained parasitophorous vacuole (PV) 
proteins and Maurer’s clefts proteins while 5000g-30,000 g pellets showed mostly 
erythrocyte marker proteins. In the 80,000 g fraction, we detected the presence of 
PFE55-GFP as well as PfHsp70x, but not PfSERP, PfSBP1 and PfEXP1, indicating 
that the J-dots fraction was pure without containing any marker proteins of Maurer’s 
clefts and parasitophorous vacuole membrane (PVM). However, red blood cell 
membrane protein marker Glycophorin A/B was present in every fraction including the 
80,000 g fraction suggesting that this fraction also contained some fragments of 
erythrocyte plasma membrane. In the 10x 104 g fraction, the signal from PFE55-GFP 
and PfHsp70x as well as the others protein markers were absent. 
 
Figure 3.1: Western blot analysis of different fractions from differential 
ultracentrifugation 
The pellets from 1000 g-10x 104 g by different centrifugation were verified by using anti-GFP (J-dots), anti-
PfHsp70x, anti-PfSERP, anti-PfSBP1, anti-PfAldolase, anti-PfEXP1 and anti-GlycophorinA/B. 
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 Detection and identification of protein complexes 3.2
separated by BN-PAGE and 2D BN/SDS-PAGE 
In order to characterize the molecular PFE55-PfHsp70 chaperone/co-chaperone 
complex in the J-dot fraction, a BN-PAGE gel was applied to separate the multiple 
protein complexes of the 80,000 g fraction, followed by with the detection via 
immunoblot analysis and identification by LC-MS/MS. In addition, an immunoblot of 2D 
BN/SDS-PAGE was performed for further analysis of the J-dot complexes. 
3.2.1 Immunoblot analysis and protein identification of BN-
PAGE by LC-MS/MS  
Proteins of the 80,000 g fraction of PFE55GFP transfection cell line and control 3D7 wild 
type cell line were separated on the BN-PAGE, followed by immunoblot analysis using 
anti-GFP as well as mass spectrometry identification.  
In this experiment, the non-ionic detergent digitonin and dodecylmaltoside (DDM) were 
chosen for solubilsation as well as stabilization of protein complexes in the J-dots 
fraction. By adding the DDM, a clear signal was observed at the height of >232kDa 
(Figure 3.2) in immunoblot analysis with anti-GFP and anti-PfHsp70x. However, with 
digitonin solubisation, two clear signals were found, one signal at around 232kDa, and 
the other one around 440 kDa~669kDa (Figure 3.2A), As digitonin was more 
solubilizes and stabilizes supercomplexes while DDM possible leads to the dissociation 
of these structures into a single protein complexes. This result suggests that a 
PfHsp70x and PFE55 chaperones/co- chaperones complex in J-dots has a molecular 
weight of at least of ~223-440kDa.  
Based on these observations, five bands were chosen and sliced from the 
corresponding gel, followed by in gel-digestion with trypsin and proceeded protein 
identification by LTQ-Orbitrap Elite Mass spectrometry (Figure 3.2 B). The peptides 
masses and sequences information were searched against the Plasmodium DB 
database by using Pfind (2.0) engine and identified by two unique peptides matching. 
Here, the proteins were selected based on the presence of an export domain, 
transmembrane domain or signal peptide (Table 3.1, Table 3.2). PfHsp70x was found 
in two samples, band 2 (Table 3.1) and band 3 (Table 3.2) with two unique peptides 
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matching, respectively. In band 2 (Table 2.1), the following exported proteins from P. 
falciparum were identified including:  PfHsp70x, PfSEMP1, PfG174, REX1, PfGBP130, 
DnaJ protein, Pfj2, CPN60, RON3, MSP7, SEC7, RAP3, RAP2, RhopH3 and RhopH2. 
In band 3 (Table 2.2), several exported PfHsp70x, PfSEMP1, PfGEXP18, MSP1, 
CPN60 and RhopH2. Among those, most of the proteins belong to known protein 
complexes with a high abundance in the infected red blood cell. For example, RAP2 
and RAP3 are members of low molecular weight rhoptry complexes (Baldi et al., 2000), 
in contrast to RhopH3 and RhopH2 which are components of high molecular weight 
rhoptry complexes (Doury et al., 1994). RON3 associates to the Plamodium rhoptry 
neck (RON) protein complex (Cowman et al., 2012). PfSEMP1 is a new Maurer’s clefts 
membrane protein and was identified during a co-immunoprecipitation with PfHsp70x 
(Dietz et al., 2014). In addition, more unknown proteins were identified along with 
PfHsp70x, in the same band, PfG174 is a PHISTb family protein with unknown function 
and found in the infected erythrocyte ghosts (Vincensini et al., 2005). Moreover, 
PfGBP130 was detected which is a soluble protein found in the host cell cytoplasm with 
an unknown function (Benting et al., 1994). DnaJ and Pfj2 are both belonged to type II 
J-protein family (Hohfeld et al., 1995). PfGEXP18 is a Plasmodium exported protein 
with unknown function. Further, CPN60 was identified in all five bands, which is a 
chaperone protein with a molecular weight of 60kDa. Unfortunately, the PFE55-GFP 
was not detected in all five bands. Considering the high abundance of identified 
proteins like the high RhopH2 with 17 unique peptides identified and SCE with 11 
unique peptide identified, it might be that either PFE55 was not presented in these 
bands or the identification was shadowed by the high abundance of other proteins. 
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Figure 3.2: Immunoblot analyses protein complexes isolated by BN-PAGE in J-
dots fraction. 
The 80,000 g fraction pellet from trophozoite stage parasite of PFE55GFP transfection cell line and 3D7 cell 
line was solubilsation by dodecylmaltoside (DDM) and separated on the BN-PAGE followed by western 
blotting using anti-GFP (PFE55-GFP), anti-PfHsp70x and anti-PfAldolase (control). HMW Native markers 
were used as a standard (kDa). 
 
 
Figure 3.3: Immunoblot analyses and LC-MS/MS identification of protein 
complexes isolated by BN-PAGE in J-dots fraction. 
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A: The 80,000 g fraction pellet from trophozoite stage parasite of PFE55GFP transfection cell line and 3D7 
cell line was separated on the BN-PAGE followed by western blotting using anti-GFP (PFE55-GFP), HMW 
Native markers were used as a standard (GE Healthcare) B: Five bands were excised form BN-PAGE and 
digested with trypsin for further LC-MS/MS analysis. 
 
 
Table 3.1: Protein identification of band 2 by LC/MS/MS (exported protein list). 
 Accession 
Number Protein names 
Unique 
Peptide 
Number 
Percent 
Coverage Molecular Weight 
PF3D7_0629200 DnaJ protein, putative 3 6.316 44,669 
PF3D7_0702400 
small exported membrane 
protein 1 (SEMP1) 
2 15.447 
14,195 
PF3D7_0731300 
Plasmodium exported protein 
(PHISTb), unknown function 
(PfG174) 
2 6.309 
37,723 
PF3D7_0831700 
heat shock protein 70 
(HSP70x) 
2 3.829 
75.054 
PF3D7_0935900 ring-exported protein 1 (REX1) 4 4.067 83,041 
PF3D7_1016300 
glycophorin binding protein 
(GBP) 
3 18.932 
95,844 
PF3D7_1108700 heat shock protein DnaJ 
homologue Pfj2 
2 5 
62,377 
PF3D7_1232100 60 kDa chaperonin (CPN60) 5 9.053 81,484 
PF3D7_1252100 rhoptry neck protein 3 (RON3) 4 1.851 263,155 
PF3D7_1335100 
merozoite surface protein 7 
(MSP7) 
2 5.698 
41,276 
PF3D7_1442900 protein transport protein SEC7, 
putative (SEC7) 
11 1.684 
404,583 
PF3D7_0501500 
rhoptry-associated protein 3 
(RAP3) 
2 4.75 47,004 
PF3D7_0501600 rhoptry-associated protein 2 
(RAP2) 
3 8.543 46,739 
PF3D7_0905400 
high molecular weight rhoptry 
protein 3 (RhopH3) 
6 7.581 104,856 
PF3D7_0929400 
high molecular weight rhoptry 
protein 2 (RhopH2) 
17 13.57 162,665 
 
 
Table 3.2: Protein identification of Band 3 by LC/MS/MS (exported protein list). 
Accession 
Number Protein names 
Unique 
Peptide 
Number 
Percent 
Coverage Molecular Weight 
PF3D7_0402400 
Plasmodium exported protein, 
unknown function (GEXP18) 
2 8.661 31,019 
PF3D7_0702400 small exported membrane protein 
1 (SEMP1) 
2 15.447 
14,195 
PF3D7_0831700 heat shock protein 70 (HSP70x) 2 3.387 75.054 
Results 
 47 
PF3D7_0929400 
high molecular weight rhoptry 
protein 2 (RhopH2) 5 3.193 162,665 
PF3D7_0930300 
merozoite surface protein 1 
(MSP1) 
6 4.128 
195,726 
PF3D7_1016300 glycophorin binding protein (GBP) 2 17.112 95,844 
PF3D7_1232100 60 kDa chaperonin (CPN60) 3 5.153 81,484 
PF3D7_1456800 
V-type H(+)-translocating 
pyrophosphatase, putative (VP1) 
2 3.347 76,417 
3.2.2 2D BN/SDS-PAGE and western blot analysis of protein 
complexes that contained PFE55/PfHsp70x in J-dots 
fraction 
Multiple complexes that contained PEF55-GFP and PfHsp70x were isolated from 
80,000 g J-dot fraction by BN-PAGE and following western blotting; while an additional 
secondary dimension SDS-PAGE was performed to prove the presence of PEF55-GFP 
and PfHsp70x from the same protein complex with high molecular weight.  
After multiple complexes were separated on the first dimension BN-PAGE, the gel lane 
with the protein complexes was subsequently denatured and further separated on a 
10% SDS-PAGE. Western blotting was performed using anti-GFP and anti-PfHsp70x, 
respectively. As shown in Figure 3.3, by usage of the anti-PfHsp70x antibody three to 
four signals with a molecular weights ~75kDa could be detected Signals were initially 
identified on BN-PAGE at height of  >669kDa, 440kDa~669kDa and 232kDa~440kDa 
(it seems like there was more than one signal detected at the height of 
440kDa~669kDa). With the anti-GFP, were two strong signals and a week signal spot 
with a molecular weights of ~70kDa was detected. Signals were present at the height 
of >669kDa, 440kDa~669kDa and 232kDa~440kDa on BN-PAGE, respectively. 
Comparing the signal from anti-GFP and anti-PfHsp70x which were running at a similar 
molecular mass as in the initial BN-gel, which was indicated that PFE55-GFP and 
PfHsp70 came from the same high molecular weight complex. The first lane was 
loaded with 80,000 g fraction and severed as a positive control. 
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Figure 3.4: 2D BN/SDS-PAGE immunoblotting analysis J-dots protein complex. 
The protein sample of 80000 g fraction was subjected to 2D BN/SDS-PAGE (4–15% and 10%, 
respectively), and further preceded for immunoblot analysis with anti-PfHsp70x and anti-GFP (PfHsp40-
GFP). Lane1: Positive control (80,000g cell lysate fraction).  
 In vivo crosslinking and co-immunoprecipitation 3.3
(co-IP) 
The result from 2D BN/SDS PAGE immunoblotting suggests that PFE55-GFP and 
PfHsp70x were present in the same high molecular complex. In order to investigate 
other interaction partners PFE55-PfHsp70x, co-immunoprecipitation (co-IP) was 
performed. In addition to this and in order to enhance the protein-protein interaction as 
well as to stabilise transient protein-protein interactions, an in vivo cross-linking 
reaction was done in prior the to the co-IP analysis, an overview of the experimental 
set up is shown in Figure 3.4. 
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Figure 3.5: The diagram shows the experimental setup of in vivo crosslinking and co-
Immunoprecipitation assays. 
3.3.1 Identification of interacting proteins partners by 
immunoprecipitation via PMF  
The western blotting of 2D BN /SDS PAGE suggests a molecular weight of J-dot 
protein complexes of more than 223 kDa, in order to detect the association of PfHp70x 
with both exogenous PFE55-GFP and endogenous PFE55, a pull-down experiment 
with anti-GFP antibody was performed on PFE55-GFP parasites cell line and 3D7 
parent parasites as control.. The eluted proteins were separated on a 12% SDS-PAGE 
and visualized by commassie staining. Compared to the negative control, two unique 
bands were present in the elution from co-IP assays using GFP as baits. The first band 
has a molecular weight of ~70kDa, while the other ~40kDa. These two bands were 
excised and subject to an in gel digestion with trypsin. Thereby samples were prepared 
for MALDI-TOF mass spectrometry to obtain peptide mass fingerprinting (PMF). 
Proteins were identified by a search against Plasmodium DB database and Uniprot 
human database. The proteins from band one including consist of PFE55 (PFE55-
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GFP), PfHsp70x, and human HSC70 while PFE55 was identified in band two (Figure 
3.5).  
 
 
                                     
 
Figure 3.6: Protein identification in unique coomassie stained band by MALDI-
TOF mass spectrometry. 
Coomassie stained SDS–PAGE gels of the elution from immunoprecipitation performed using GFP 
antibody on parasite lysates from PFE55-GFP and 3D7, two unique bands were excised and analyzed by 
MALDI-TOF mass spectrometry. A pre-stain protein marker was used as a standard. 
3.3.2 In vivo crosslink with DSP 
We used an amine-reactive, thiol-cleavable and membrane permeable cross linker 
named DSP with a bond length of 12 Å for in vivo crosslinking of the cell in order to 
strengthen protein-protein interactions as well as capturing the instantaneous protein 
inactions. Western blotting with anti-GFP and anti-PfHSP70x was used for verifying the 
efficiency of in vivo cross-link in vivo by a comparison with non-crosslinked sample.  
As shown in the western blotting (Figure 3.6), the crosslinked and non-crosslinked cells 
were lysed and separated into three fractions: membrane fraction, J-dot fraction and 
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supernatant fraction. For the sample with crosslinking, the PfHsp70x was observed in 
complexes (>250kDa) present mostly in the membrane fraction (30,000 g) and J-dot 
fraction (80,000 g) but rarely in the supernatant fraction. Most of the monomeric 
PfHsp70x was present in the supernatant while only a small amount was detectable in 
the membrane fraction at a size of around 70 kDa. This data imply that most of the 
PfHsp70x is present as higher ordered structure in the J-dot fraction and membrane 
fraction (Figure 3.6).  
 
 
                             
 
Figure 3.7: Cross-link captures PfHsp70x complexes in different cell fraction.  
Trophozoite stage P. falciparum infected red blood cell parasites were treated with cross-linker DSP at 
1.5mM, then differential centrifuged at 3x104 g, 8x104 g after lysed. The supernatant, and the pellet from 
membrane fraction and J-dots fraction was separated by SDS-PAGE under non-reduced conditions. A: 
western blotting analysis with a polyclonal anti-PfHsp70x antibody. 
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3.3.3 Identification of the protein from co-immunoprecipitation 
(co-IP) using LC-MS/MS 
As the results above show, the protein complex contained PFE55-GFP and PfHsp70x 
in a high molecular weight. In order to investigate the other proteins associating with 
PfHsp40 and PfHsp70x, we performed two groups’ co-IP assays with anti-GFP and 
anti-PfHsp70x on PFE55GFP transgenic cell line. The interaction partners of PFE55 
were captured by co-elution with PFE55-GFP after incubating cell lysates with anti-
GFP affinity beads; while lysates from the 3D7 control cell line were used as a negative 
control. Meanwhile, PfHsp70x associating proteins were identified by co-IP assays 
using anti-PfHsp70x affinity beads in PFE55GFP lysate and non-antibody beads were 
used as a control.  
The elution protein was subject to 12% SDS-PAGE gel and visualized by commassie 
blue. Proteins from both IP and control were in gel digested with trypsin and analyzed 
by LTQ-Orbitrap Elite mass spectrometry. The entire protein list is shown in Table S1. 
All identified proteins were using ≥ 2 unique peptides matches were used and we 
further selected the interaction partners by either of the following characteristics: i) 
proteins containing a classical N-terminal signal sequence only, ii) proteins having a 
predicted PEXEL/HT export motif OR an annotation as "exported", iii) proteins 
exhibiting a hydrophobic domain.  In addition, the specific binding proteins were picked 
up by the ratio ≥2 of identified unique peptide number in comparison to the control. In 
theory, the higher ratio value it has, the more specific binding opportunity of 
identification protein.  
In total 73 P. falciparum proteins co-eluted with PFE55-GFP. Amongst of these, four 
exported proteins, two proteins with a signal peptide and one protein containing a 
transmembrane domain (Table 3.3). The proteins were further selected by a peptide 
ratio ≥ 2 compared to control identified unique peptide number. We ended up with are 
PFE55, PfHsp70x, PfPHISTc, DnaJ protein, plasmepsin IV, PfHsp101.  
From the co-IP assays with PfHsp70x as a bait protein, there were 190 P. falciparum 
proteins identified with ≥ 2 unique peptides matching, including nine exported proteins, 
20 proteins with signal peptide and eight proteins containing transmembrane domain 
(Table 3.4). By comparison with the negative control, 23 proteins were with a unique 
peptide number ratio ≥ 2. Interestingly, two P. falciparum proteins, PfPHISTc and 
Results 
 53 
PfHsp101 were found to be potentially binding to both PFE55-GFP and PfHsp70x. In 
addition, these two proteins exhibit different subcellular location. PfHsp101 is a 
component of PTEX translocon complex that localizes to the PVM and faces to PV (de 
Koning-Ward et al., 2009). PHISTc belongs to the PHIST protein family protein, and is 
potentially localized in the erythrocyte cytosol. In previous study, J-dots have been 
demonstrated to localize in the erythrocyte cytosol, which suggests that PHISTc is a 
member of the J-dot protein complex by binding to PFE55 and PfHsp70x. Moreover, 
PfHsp101 was identified by LC-MS/MS with a five fold and four fold of unique peptide 
in co-IP with anti-GFP and anti-PfHsp70x, respectively. This is highly suggestive that a 
protein complex containing PFE55/PfHsp70x is also found in the PV. Besides 
PfHsp101 and PfPHISTc, there were more proteins identified that highly associate with 
PfHsp70x, including PfGEXP18, PfGBP130, PHIST protein, PfEXP2, and PfPV1. 
Interestingly, PfEXP2, another protein component of PTEX translocon as well as 
PfHsp101 were found in PfHsp70x pull down. Furthermore, in a recent study, PfPV1 
and PfHsp70x were identified to immunoprecipitation with an essential PTEX 
translocon component-PTEX150 (Elsworth et al., 2016). As two components of PTEX 
translocon bound PfHsp70x, further analysis of the interaction between members of the 
PTEX translocon and PfHsp70x was carried out.  
It has long been suggested that parasite encoded Hsp40s potentially interact with 
human Hsp70. In order to verify the interaction between PFE55, PfHsp70x and human 
protein, all of the raw data were search against Uniprot human database. With ≥ 2 
unique peptides matching, in total 87 proteins and 59 proteins were identified by co- 
immunoprecipitation with anti-GFP and anti-PfHsp70x respectively. We first excluded 
removed high abundant proteins including trypsin, keratin, myosin, and ribosomal 
proteins. The remaining proteins with unique peptide number ratio ≥ 2 are selected. In 
our study, we only interested the interactions between human Hsp70 and 
PFE55/PfHsp70x. As shown in the list (Table 3.5), two HsHsp70 proteins were 
identified in immunoprecipitation with PFE55-GFP. HSP74_HUMAN, a heat shock 
70kDa protein 4 (HSP70RY) and GRP78_HUMAN, a 78 kDa glucose-regulated protein 
(GRP-78) with unique peptide ratio of three fold and four fold compared to control, 
respectively. This is highly suggests that PFE55 interacts with human Hsp70. Because 
of high homology, between GRP_human and parasite encoded heat shock protein 70 
(HSP70-2) (64.384% identity), HSP70RY shares 30-40% homology with many 
parasite-encoded heat shock proteins, such as Hsp70x and Hsp110c. Therefore, it is 
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difficult to verify these data without more specific antibodies working with double 
species systems. In our study, although many of human Hsp70 protein peptides were 
found by precipitated with PfHsp70x. However, most of the peptide was not unique 
peptide, therefore, they couldn’t take into account in our analysis. However, GRP-78, 
only was identified by binding with anti-PfHsp70x with 1 unique peptide and 2 peptide 
identification, but not found in control sample, which was still suggested the possibility 
the interaction between GRP-78 and PfHsp70x.  
 
Table 3.3: Proteome identification of co-immunoprecipitation against with anti-
GFP by LC/MS/MS (Plasmodium DB database). 
Exported N=5 
Accession 
Number Protein names 
Unique 
Peptide 
Number 
Peptide 
Coverage 
Unique 
Peptide 
Number 
Peptide
Coverag
e 
Ratio 
 
PF3D7_0501100.
1/2 
heat shock protein 40, type II 
(PFE55) 6 15.423 0 0 6/0 
PF3D7_0801000 
Plasmodium exported protein 
(PHISTc), unknown function 3 4.102 0 0 3/0 
PF3D7_1401100 DnaJ protein, putative 8 22.561 1 1.829 8 
PF3D7_1407800 plasmepsin IV (PM4) 3 12.695 1 4.677 3 
PF3D7_0831700 
heat shock protein 70 
(HSP70x) 17 34.866 6 15.464 2.83 
Signal peptide N=3 
PF3D7_0929400 
high molecular weight rhoptry 
protein 2 (RhopH2) 7 7.329 4 5.007 1.75 
PF3D7_1116800 
heat shock protein 101 
(HSP101) 5 9.272 0 0 5/0 
PF3D7_1471100 exported protein 2 (EXP2) 3 9.756 2 8.362 1.5 
TM Domain N=2 
PF3D7_1408100 plasmepsin III (HAP) 2 5.965 0 0 2/0 
 
 
 
 
Table 3.4: Proteome identification of co-immunoprecipitation with anti-PfHsp70x 
by LC/MS/MS (Plasmodium DB database). 
Exported N=9 
Accession 
Number Protein names 
Unique 
Peptide 
Number 
Peptide 
Coverage 
Unique 
Peptide 
Number 
Peptide 
Coverage 
Ratio 
 
PF3D7_0401800 
Plasmodium exported protein 
(PHISTb), unknown function 
(PfD80) 2 4.46 0 0.00 2/0 
PF3D7_0402400 Plasmodium exported protein, 6 36.61 0 0.00 6/0 
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unknown function (GEXP18) 
PF3D7_0501100.
1/2 
heat shock protein 40, type II 
(PFE55) 4 15.92 0 0.00 4/0 
PF3D7_0721100 
conserved Plasmodium 
protein, unknown function 2 9.84 0 0.00 2/0 
PF3D7_1001400 alpha/beta hydrolase, putative 2 3.47 0 0.00 2/0 
PF3D7_1016300 
glycophorin binding protein 
(GBP) 6 46.48 0 0.00 6/0 
PF3D7_1201000 
Plasmodium exported protein 
(PHISTb), unknown function 4 6.28 0 0.00 4/0 
PF3D7_0831700 
heat shock protein 70 
(HSP70x) 38 57.44 3 12.08 12.67 
PF3D7_0801000 
Plasmodium exported protein 
(PHISTc), unknown function 9 12.22 0 0.00 9/0 
Signal peptide N=20 
PF3D7_0207600 
serine repeat antigen 5 
(SERA5) 8 15.15 1 1.81 8.00 
PF3D7_0302500 
cytoadherence linked asexual 
protein 3.1 (CLAG3.1) 2 3.25 0 0.00 2/0 
PF3D7_0827900 
protein disulfide isomerase 
(PDI8) 5 18.63 1 3.42 5.00 
PF3D7_0905400 
high molecular weight rhoptry 
protein 3 (RhopH3) 11 19.84 4 6.24 2.75 
PF3D7_0917900 
heat shock protein 70 (HSP70-
2) 19 36.35 4 7.36 4.75 
PF3D7_0929400 
high molecular weight rhoptry 
protein 2 (RhopH2) 25 25.04 6 6.39 4.17 
PF3D7_0930300 
merozoite surface protein 1 
(MSP1) 11 8.37 1 2.85 11.00 
PF3D7_1010700 
dolichyl-phosphate-mannose 
protein mannosyltransferase, 
putative 3 18.39 2 16.55 1.50 
PF3D7_1012200 
conserved Plasmodium 
protein, unknown function 5 24.72 0 0.00 5/0 
PF3D7_1015200.
1/2 
cysteine--tRNA ligase, putative 
(CysRS) 2 3.40 0 0.00 2/0 
PF3D7_1105800 
conserved Plasmodium 
protein, unknown function 3 13.53 0 0.00 3/0 
PF3D7_1116000 rhoptry neck protein 4 (RON4) 2 1.67 0 0.00 2/0 
PF3D7_1116800 
heat shock protein 101 
(HSP101) 4 6.51 0 0.00 4/0 
PF3D7_1129100 
parasitophorous vacuolar 
protein 1 (PV1) 5 14.82 2 5.75 2.50 
PF3D7_1222300 
endoplasmin, putative 
(GRP94) 7 12.42 2 3.41 3.50 
PF3D7_1232100 60 kDa chaperonin (CPN60) 8 19.36 1 1.67 8.00 
PF3D7_1252100 rhoptry neck protein 3 (RON3) 9 5.60 0 0.00 9/0 
PF3D7_1454400 aminopeptidase P (APP) 17 29.09 8 13.26 2.13 
PF3D7_1471100 exported protein 2 (EXP2) 4 14.98 1 3.83 4.00 
TM Domain N=8 
PF3D7_0220000 liver stage antigen 3 (LSA3) 3 2.95 0 0.00 3/0 
PF3D7_0801800 
mannose-6-phosphate 
isomerase, putative 2 2.57 1 1.09 2.00 
Results 
 56 
PF3D7_0811200 
ER membrane protein 
complex subunit 1, putative 
(EMC1) 4 5.21 0 0.00 4/0 
PF3D7_0823800 DnaJ protein, putative 3 8.40 0 0.00 3/0 
PF3D7_1037300 
ADP/ATP transporter on 
adenylate translocase (ADT) 3 15.62 0 0.00 3/0 
PF3D7_1105800 
conserved Plasmodium 
protein, unknown function 3 13.53 0 0.00 3/0 
PF3D7_1311800 
M1-family alanyl 
aminopeptidase (M1AAP) 12 17.51 1 2.58 12.00 
PF3D7_1459400 
conserved Plasmodium 
protein,  2 7.94 0 0.00 2/0 
 
 
Table 3.5: Human heats shock 7 identification of co-immunoprecipitation with 
anti-GFP by LC/MS/MS (Uniprot Human Database)(ratio>2). 
Accessio
n Number 
Entry 
name  Protein names 
Unique 
Peptide 
Number 
Peptide 
Coverage 
Unique 
Peptide 
Number 
Peptide
Coverag
e 
Ratio 
 
P34932  
HSP74
_HUMA
N 
 
Heat shock 70 kDa protein 
4 (HSP70RY) (Heat shock 
70-related protein APG-2) 3 15.238 1 1.667 3 
P11021 
GRP78
_HUMA
N 
78 kDa glucose-regulated 
protein (GRP-78) 
(Endoplasmic reticulum 
lumenal Ca(2+)-binding 
protein grp78) (Heat shock 
70 kDa protein 5) 
(Immunoglobulin heavy 
chain-binding protein) (BiP) 3 21.407 0 8.716 3 
 
 
 
 
3.3.4 Detection of identification proteins in co-
immunoprecipitation (co-IP)  
In this study, all of the potential interactions between PfHsp70x, PFE55 were verified 
by immunoblotting with the available working antibodies including the monoclonal 
mouse anti-GFP, polyclonal rabbit anti-PfHsp70x, monoclonal mouse anti-PfHsp101, 
polyclonal rabbit anti-PfGBP130, polyclonal rabbit anti-PfPHISTc, monoclonal mouse 
anti-human Hsp70, polyclonal rabbit anti-PfEXP2 and polyclonal rabbit anti-PfPV1. 
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So far, four parasite encoded proteins PFE55-GFP, PfHSP70x, PfPHISTc and 
PfHsp101 as well as a human heat shock 70 were identified in both co-
immunoprecipitation (co-IP) assays with anti-GFP and anti-PfHsp70x, which were 
further confirmed by immunoblotting against anti-GFP, anti-PfHsp70x, anti-PfHsp101, 
anti-PfPHISTc and anti-human Hsp70 using co-IP elution, respectively. To rule out 
non-specific binding during co-IP procedure, a co-IP with anti-GFP was performed on 
3D7 wild type parasites; while for the co-IP with anti-PfHsp70x. the same procedure 
was applied using non-antibody-conjugated beads as empty control (Figure 3.7 A,B).  
PfGBP130 was found to potentially associate with PfHsp70x in both BN-PAGE and co-
IP mass spectrometry data. This interaction was further verified by immunoblot analysis 
using anti-PfGBP130 (Figure 3.7B). In addition, PfEXP2 and PfPV1 was also verified to 
be bound with PfHsp70x but not PFE55 (Figure 3.7A,B) 
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Figure 3.8: Western blot verification of protein-protein interactions. 
A. Western blotting analysis of co-Immunoprecipitation using anti-GFP with lysates of PFE55GFP and 3D7 
strains (control). B. Western blot analysis of co-Immunoprecipitation with lysates of PFE55GFP strain using 
PfHsp70 antibody-conjugated beads or empty bead only (control). UB: lysate. B: binding. The antibodies 
used including monoclonal mouse anti-GFP, polyclonal rabbit anti-PfHsp70x, monoclonal mouse anti-
PfHsp101, polyclonal rabbit anti-PfPHISTc monoclonal mouse anti-human Hsp70. polyclonal rabbit anti-
PfEXP2, polyclonal rabbit anti-PfGBP130 and polyclonal rabbit anti-PfPV1. 
 Protein complex containing 3.4
PfPHISTc/PFE55/PfHsp70x 
Our mass spectrometry suggests that PfHISTc is incorporated with PfHsp70x and 
PFE55, which was further verified by western blotting with anti-PfPHISTc antibody. In 
order to investigate if the PfPHISTc/PFE55/PfHsp70x containing protein complex 
contains is a J-dot protein complex and if it localizes to the parasite-infected 
erythrocyte cytosol; an immunoblot of two- dimensional BN/SDS-PAGE and a co-
immunofluorescence were carried out.  
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3.4.1 Protein complex verification by using western blotting of 
2D BN/SDS-PAGE  
To further confirm that three exported proteins, PFE55-GFP, PfHsp70x and PfPHISTc 
build a protein complex; the immunoblotting of 2D BN/SDS-PAGE was performed on 
the J-dot fraction of PFE55GFP cell lysate.  
The protein sample from 80,000 g (J-dot fraction) was separated on the first dimension 
on 4-15% gradient BN-PAGE, and then subject to a second dimension of a 10% SDS-
PAGE and subsequently detected using specific antibodies including monoclonal 
mouse anti-GFP, polyclonal rabbit anti-PfHsp70x, and polyclonal rabbit anti-PfPHSITc; 
Meanwhile, polyclonal rabbit anti-PfHsp70-1 was used as negative control. As shown in 
the figure 3.8, although the signal was not present as a clear spot due to low quality of 
PfPHISTc antibody; nevertheless, the signal in immunoblotting of the second 
dimensional gel showed that three of proteins at present at the similar position with 
high molecular weights around 440kDa. The result suggests PfPHISTc associats with 
E55-GFP and PfHsp70x as one of J-dot protein component. 
                  
Figure 3.9: Western blotting of 2D BN/SDS-PAGE with J-dots protein complex. 
The 80,000 g fraction from PFE55GFP lysate was subjected to 2D BN/SDS-PAGE (4–15% and 10%, 
respectively), followed by the subsequent immunoblot analysis with monoclonal mouse anti-GFP (1:500 
dilution), polyclonal rabbit anti-PfHsp70x (1:500 dilution), polyclonal rabbit anti-PfPHSITc(1:1000 dilution). 
Non-specific binding was controlled by immunoblotting with anti-PfHsp70-1. 
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3.4.2 PfPHISTc partially localizes to the J-dots 
PfPHISTc was likely to be the third component of the J-dots according to the results 
from co-immunoprecipitation (co-IP) with anti-GFP and anti-PfHsp70x as well as 2D 
BN/SDS-PAGE. In pervious a study, it has been shown that PfHsp70x partially 
localizes to the J-dots. Here, the immunofluorescence analysis was performed on 
PfPHISTcGFP transfected parasite line. As shown in the Figure 2.9, PfHsp70x localizes 
to the erythrocyte and PV; while PfPHISTc indicated by green fluorescence localizes to 
erythrocyte. The partial co-localization of PfPHISTc and PfHsp70x was shown as 
yellow florescence in the overlay image, which mostly locates in cytosol of the infected 
red blood cell  (Figure 3.9) 
 
 
 
Figure 3.10: PfHsp70x co-localizes with PfPHISTc. 
Fluorescence channels are shown individually in black and white, partial co-localization was observed in 
merged and overlay images. The polyclonal chicken anti-GFP antibody (green) and polyclonal anti-
PfHsp70x antibody (red) were used in this analysis. 
 PfGEXP18 is another J-dots protein associated 3.5
with PfHsp70x 
PfGEXP18 is a Plasmodium exported protein previously been identified as a 
gametocyte protein with unknown function, which was identified in both BN-PAGE and 
pull down assay using anti-PfHsp70x by LC-MS/MS. Because of the lack of specific 
antisera against PfGEXP18, GEXP18GFP parasites were generated by Sonja Engels 
based on 3D7 wild type cell line expression PfGEXP18-GFP fusion protein to further 
verify the interaction between PfPfHsp70x and PfGEXP18. 
A co-immunoprecipitation (co-IP) was carried out on PfGEXP18GFP lysate of in vivo 
cross-linking with monoclonal mouse anti-GFP antibody beads; while 3D7 cell line was 
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used as control. The binding proteins were eluted and preceded for the immunoblot 
shown in the Figure 3.10, both of the proteins were observed in the elution. 
 
 
 
Figure 3.11: Western blot analysis PfGEXP18GFP with PfHsp70x.  
Cell lyate was immunoprecipitated with anti GFP after in vivo crosslink cell.  B, elution of co-
immunoprecipitation, UB, supernatant of lysate, 3D7 wild –type cell line as a negative control. The pulled 
down complex were analysis by western blotting with antibody anti-GFP and anti-PfHsp70x. 
 
 PfGBP130 associates with PfHsp70x and belongs 3.6
to a new protein complex 
PfGBP130 was found to interact with PfHsp70x according to the result of BN-PAGE as 
well as co-immunoprecipitation (co-IP). In order to further confirm the specific 
interaction between them, a co-IP with polyclonal rabbit anti-PfGBP130 was performed 
on PFE55GFP lysate while the beads without antibody were used as negative control. 
After elution, both PfGBP130 and PfHsp70x were detected in the immunoblot analyses 
using anti-PfGBP130 and anti-PfHsp70x, respectively, indicating a close contact 
between each other in vivo (Figure 3.11). 
In addition, the co-localization analysis of PfGBP130 and PfHsp70x was performed 
using monoclonal mouse anti-PfGBP130 and polyclonal rabbit anti-PfHsp70x. In order 
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to avoiding the green florescence from GFP, therefore, 3D7 cell line was used in this 
section. As shown in the figure 3.12, PfGBP130 (labeled in green fluorescence), 
exhibits more intense signal and appears predominantly in vesicles as well as in the 
erythrocyte cytoplasm and the PV. It also partially co-localizes with PfHsp70x as shown 
by yellow fluorescent in both the PV and erythrocyte.  
 
 
Figure 3.12: Western blot analysis of interaction between PfGBP130 and 
PfHsp70x.  
Co-Immunoprecipitation with polyclonal rabbit anti-PfGBP130 was performed on PFE55GFP lysate and 
verified with anti-PfGBP130 and polyclonal rabbit anti-PfHsp70x. B: elution of co-immunoprecipitation. UB: 
cell lysate was used as positive control. Co-immunoprecipitation with non-antibody beads were used as 
negative control.  
  
 
Figure 3.13: PfHsp70x co-localizes with PfGBP130. 
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Fluorescence channels are shown individually in black and white, co-localization was observed in merged 
and overlay images. The monoclonal anti-PfGBP130 antibody (green) and polyclonal anti-PfHsp70x (red) 
were used in the analysis 
 The interaction between PfHsp101 and PfHsp70x 3.7
was verified by co-immunoprecipitation with anti-
PfHsp101 
PfHsp101 was found to associate with both PfHsp40 and PfHsp70x in co-
immunoprecipitation (co-IP) assay. In order to confirm the specific interaction between 
them, a co-IP assay with monoclonal mouse anti-PfHsp101 was performed on 
PFE55GFP lysate and beads without antibody were used as negative control. The 
binding proteins were eluted and detected by immunoblot analyses using the anti-
PfHsp101, anti-PfHsp70x and anti-GFP. PfHsp70x was found in the pull down with 
PfHsp101 but not with PFE55-GFP, indicating that PfHsp70x indeed is in close contact 
with PfHsp101 (Figure 3.13).  
Besides of co-IP and co-localization analysis of PfHsp101 and PfHsp70x was also 
performed on 3D7 parasite cell line using monoclonal mouse anti-PfHsp101 and 
polyclonal rabbit anti-PfHsp70x antibody. In order to avoiding the green florescence 
from GFP, 3D7 cell line was used in this analysis instead of PFE55-GFP transgenic cell 
line. In the previous study, PfHsp101 has been found as a component of PTEX 
translocon in the PVM (de Koning-Ward et al., 2009). As shown in the figure 3.4, 
PfHsp101 (green fluorescence) surrounded in the membrane; while PfHsp70x partially 
co-localized with PfHsp70x (yellow fluorescence) (Figure 3.14). 
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Figure 3.14: Western blotting analysis of interaction between PfHsp101 and 
PfHsp70x.  
Co-Immunoprecipitation with monoclonal mouse anti-PfHsp101 was performed on PFE55GFP lysate and 
verified with anti-PfHsp101 and polyclonal rabbit anti-PfHsp70x. B: elution of co-immunoprecipitation. UB: 
cell lysate was use as positive control. Co-immunoprecipitation with non-antibody beads was used as 
negative control.  
 
        
 
Figure 3.15: PfHsp70x co-localizes with PfHsp101. 
Fluorescence channels are shown individually in black and white, co-localization was indicated in merge 
and overlay. The analysis was performed using monoclonal anti-PfHsp101 (green) and polyclonal anti-
PfHsp70x (red).   
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 The interaction between PfHsp101 and PfHsp70x 3.8
is sensitive to proteinase K treatment 
3.8.1 LC-MS/MS identification of PfHsp70x interaction protein 
from cell lysates after Streptolysin O -Proteinase K 
protection assay  
PfHsp101 and several more proteins were found in association with PfHsp70x by co-
immunoprecipitation (co-IP) and were further verified with western blotting and co-
immunofluorescence assay. To determine subcellular locations of these protein 
complexes, a streptolysin O with proteinase K protection assay was performed, while 
saponin lysis was used as the control. After SLO and saponin permeabilization lysis 
and proteinase K treatment, the pellet fractions were lysed, proceeded by co-IP with 
anti-PfHsp70x antibody and identified with following LC-MS/MS and verified with 
immunoblot (Figure 3.15) 
SLO (streptolysine O) is a membrane damage toxin secreted by Streptococcus 
pyogenes. SLO can permeabilize the host red blood cell membrane while leave the PV 
(parasitophorous vacuole) stays. SLO binds to surface exposed membrane 
cholesterols and induces a 30nm hole in the membrane (Bhakdi et al., 1985; Jackson 
et al., 2007). Saponin is a glycoside, which is commonly found in plants and which is 
known to disintegrate the erythrocyte membrane and the parasitophorous vacuolar 
membrane of P. falciparum and leaves the parasite interacting with cell membrane 
cholesterol, leading to the permeabilization of the membrane (Beaumelle et al., 1987) 
 First of all, the in vivo cross-linked PFE55GFP cells were permeabilized with streptolysin 
O. The supernatant fraction contained erythrocyte cytosol; while pellets contained 
permeablilized red blood cell membrane, PVM, and the intact parasite. After saponin 
lysis, the supernatant fraction of contained erythrocyte cytosol and PV cytosol, while 
the pellet contained permeablilized red blood cell membrane, PVM and the intact 
parasite. The pellet fraction was then treated with proteinase K in order to verify if the 
protein complexes were located at the parasitophorous vacuole. Proteins whose C 
terminus exposed to erythrocyte cytosol were degraded.  
PfSERP as a soluble PV protein was used as a control to demonstrate that PV was still 
intact and could be found in the pellet fraction after SLO lysis. In contrast to saponin 
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lysis, where PfSERP was present in the supernatant at the size of 140kDa, indicating 
the PVM was lysed successfully lysed. In addition, human Hsp70 was used as a red 
blood cytosol marker protein that was found in the supernatant fractions in both 
treatments. PfAldolase as a parasite cytosol protein was found in the pellet of both SLO 
and saponin lysate at a size of approximately 45 kDa, which indicates that the parasite 
remained intact after lysis (Figure 3.16).  
The pellet from SLO and saponin lysate was treated with proteinase K followed lysis 
and co-IP with polyclonal rabbit anti-PfHsp70x antibody. The identification of binding 
proteins by mass spectrometry was shown in table 3.6 with two unique peptide 
matching. Totally, 52 parasite encoded proteins were identified and specific binding 
protein were selected containing either i) containing a classical N-terminal signal 
sequence only, ii) having a predicted PEXEL/HT export motif OR an annotation as 
"exported", or iii) having a hydrophobic domain. Surprisingly, PfHsp101 was not 
anymore identified in pulled down with PfHsp70x after treat with proteinase K, 
indicating that proteinase K assay break the interaction between PfHsp101 and 
PfHsp70x. Interestingly, PFE55 was found in the pellet fraction associating with 
PfHsp70x, in contrast to previous hypothesis that PFE55-PfHsp70x forms a J-dot 
protein complex which exclusively localizes to iRBC cytosol (Kulzer et al., 2012). In 
addition, PfGBP130 was identified to interact with PfHsp70x in the parasitophorous 
vacuole, which suggests that the interaction between PfHsp70x and PfGBP130 was 
present in both erythrocyte cytosol and parasitophorous vacuole.  
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Figure 3.16: A whole work flow of co-IP analysis PfHsp70x interaction protein 
after streptolysin O and proteinase K protection assay. 
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Figure 3.17: Western blotting analyses SLO and saponin lysis. 
The PFE55GFP cells were enriched and lysed with SLO and saponin; after centrifugation, the supernatant 
and pellet were separated and further analyzed by western blotting with polyclonal rabbit anti-PfSERP 
(parasitophorous vacuole), monoclonal mouse anti-PfAldolase (parasite cytosol) and monoclonal mouse 
anti-HsHsp70 (erythrocyte cytosol). 
 
 
Table 3.6: Co-immunoprecipitation with anti-PfHsp70x by LC/MS/MS 
(Plasmodium DB Database) 
Exported N=9 
Accession 
Number Protein names 
Unique 
Peptide 
Number 
Percent 
Coverage 
Unique 
Peptide 
Number 
Percent 
Coverage 
Ratio 
 
PF3D7_0501100.1
/2 
heat shock protein 40, type II 
(HSP40) 5 12.935 0 0.00 5/0 
PF3D7_1016300 
glycophorin binding protein 
(GBP) 5 42.961 0 0.00 5/0 
PF3D7_0831700 heat shock protein 70 (HSP70x) 41 55.523 3 12.08 13.67 
Signal peptide N=20 
PF3D7_0827900 
protein disulfide isomerase 
(PDI8) 3 8.075 1 3.42 3.00 
PF3D7_0917900 heat shock protein 70 (HSP70-2) 15 26.994 4 7.36 4.75 
PF3D7_0929400 
high molecular weight rhoptry 
protein 2 (RhopH2) 3 3.193 6 6.39 4.17 
PF3D7_0930300 
merozoite surface protein 1 
(MSP1) 4 2.384 1 2.85 11.00 
PF3D7_1222300 endoplasmin, putative (GRP94) 4 5.725 2 3.41 3.50 
PF3D7_1232100 60 kDa chaperonin (CPN60) 3 5.989 1 1.67 3.00 
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PF3D7_1454400 aminopeptidase P (APP) 15 26.255 8 13.26 2.13 
TM Domain N=8 
PF3D7_1311800 
M1-family alanyl aminopeptidase 
(M1AAP) 6 8.111 1 2.58 12.00 
 
 
3.8.2 Immunoblot analysis of protein interaction with 
PfHsp70x after proteinase K assay 
 
The identified proteins were further verified by western blotting against anti-GFP, anti-
PfHsp70x, anti-PfGBP130 and anti-PfHsp101; while immunoblotting of samples from 
the saponin-proteinase K assay severed as control. 
PFE55-GFP, PfHsp70x PfHsp101 and PfGBP130 were detected in the lysate from 
SLO-proteinase K assay but not in the lysate of the pellet fraction after saponin-
proteinase K assay, which indicates that these proteins were present in the PV and 
PVM. Furthermore, PfHsp70x, PFE55-GFP, and PfGBP130 were found in the elutes 
from co-immunoprecipitation (co-IP) verified by immunoblotting, which was consistent 
with the data from LC-MS/MS (Figure 3.17 B). The result suggests that PfHsp70x 
interacts with PFE55-GFP and PfGBP130 in both erythrocyte cytosol and PV.  
In section 1.3.3, PfHsp101 was shown to be interacting with PfHsp70x identified by LC-
MS/MS, and this was further proved by and co-IP with PfHsp101. However, the 
interaction between these two proteins was interrupted by proteinase K treatment. 
Therefore, interaction between PfHsp70x and PfHsp101 was most likely mediated by 
PfEXP2 that is present in the same PTEX translocon complex with PfHsp101. In 
addition, PfHsp70x was binding to this complex cross the PVM and faces the 
erythrocyte cytosol.  
The followed western blotting of SLO lysate verified the PfHsp101 was not exported 
into the erythrocyte cytosol (Figure 3.17 A). PfSERP and PfAldolase, the marker 
protein for PV and parasite cytosol, respectively, were only detected in the pellet 
fraction as well as PfHsp101; while erythrocyte cytosol protein HsHsp70 was found in 
the supernatant.  
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Figure 3.18: Western blotting analysis distribution of different PfHsp70x 
complexes in the infect red blood cell.  
A: western blotting analysis of lysates from SLO and saponin-Proteinase K protection assays on PFE55GFP 
cell line; B: Co-immunoprecipitation with anti-PfHsp70x using the pellet fraction from SLO and saponin-
Proteinase K protection assays. B: Elution of co-IP. UB: Lysate.  
B: western blotting analysis of PfHsp101 in different fractions. Antibodies used are listed as following: 
monoclonal mouse anti-GFP, polyclonal rabbit anti-PfHsp70x, polyclonal rabbit anti-PfSERP 
(parasitophorous vacuole), monoclonal mouse anti-PfAldolase (parasite cytosol) and monoclonal mouse 
anti-HsHsp70 (erythrocyte cytosol), monoclonal mouse anti-PfHsp101 and monoclonal mouse anti-
PfGBP130. 
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4 DISCUSSION 
Plasmodium falciparum exports more than 400 proteins to the infected red blood cell to 
modify its host cell in morphology, physiology and function (Hiller et al., 2004; Marti et 
al., 2004; Sargeant et al., 2006; Maier et al., 2008; Maier et al., 2009). The question of 
how exported proteins cross the parasitophorous vacuole membrane and how these 
are further secreted to the red blood cell membrane surface has been raised for long 
time. Some knowledge was added to this by the identification of highly mobile 
structures in the iRBC cytosol, referred to as J-dots. J-dots contain two parasite-
encoded chaperones Hsp40 (PFE55, PFA660) and PfHsp70x (Külzer et al. 2010, 
2012), in addition, PfHsp70x was found within parasitophorous vacuole as well. In 
order to shed some light on the role of the chaperone/co- chaperones complex 
PfHsp70x-PFE55 (J-dots) in the infected erythrocyte, in this study, multiple proteomics 
as well as biochemical methods were used. By those approaches a complete profile of 
the protein-protein interaction network containing PFE55-PfHsp70x (J-dots) was 
obtained. A full overview of the protein-protein interaction network PfHsp70x/PFE55 is 
shown in Figure 4.1. 
 Investigation of protein complexes localized in J-4.1
dots fraction 
It is always challenging to purify and identify protein complexes from a large proteome. 
High abundance proteins such as ribosome proteins, keratin, actin and many others 
cell compartment proteins always affect especially identification proteins expressed in 
low quantities. In order to investigate the protein complexes in J-dots, differential 
centrifugation, BN PAGE, 2D BN/SDS PAGE and LC-MS/MS were used to 
characterize protein complexes in J-dot.  
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4.1.1 PfHsp70x- PFE55 chaperone/co-chaperones are present 
in a common high molecular weight protein complex  
Different centrifugation has been widely used for isolating many organelles such as 
mitochondria, endosome, Golgi in different species system including Plasmodium 
(Schnaitman and Greenawalt, 1968; Krungkrai et al., 1993; Schroter et al., 1999). It is 
always used as first purification step combine with the other protein study methods for 
isolating protein and protein complex. In Plasmodium system, it has been successful 
helping isolate many protein and protein complex, such as Maurer's clefts protein, 
Rhoptry protein complex (Cao et al., 2009; Pachlatko et al., 2010) Therefore, we also 
chosen differential centrifugation as the first step to purify the J-dot fraction in our 
study. In order to get more information of this J-dot protein complex，we separated the 
J-dot fraction on a BN-PAGE. BN-PAGE is also a mature proteomics technology that 
has been wildly used for separating both cell lysate protein complex and membrane 
bound protein complex. The most important issue of BN-PAGE is to choose an 
appropriate non-ionic detergent for the solubility as well as stability of the protein 
complex. Külzer and colleagues did not reveal if J-dots are membranous structures 
(Kulzer et al., 2012). Although, Triton X-100 is suitable for cell lysates of different 
human cell lines (Camacho-Carvajal et al., 2004), it was not useful for J-dot protein 
complexes separating in BN-PAGE. In consequence, two other detergents, 
dodecylmaltoside (DDM) and digitonin, were chosen for dissolution of the J-dot 
fractions. Upon the addition of DDM, a clear GFP signal was observed at >232KDa. 
However, by using digitonin, two clear GFP signals were detected, one signal 
>232KDa, the other one >440 KDa~669KDa. This was further verified by 
immunoblotting with 2D BN/SDS PAGE, three pairs of GFP and PfHsp70x signals were 
observed >223KDa, 440-669KDa and >669KDa. Digitonin is known as a mild detergent 
that solubilizes and stabilizes supercomplexes while DDM leads to the dissociation of 
these structures into single protein complexes (Schagger and Pfeiffer, 2000).  
Therefore, the results indicate that the J-dot protein complex contains PfHsp70x and 
PFE55 at least with a molecular weight ~223-440KDa.  
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4.1.2 LC-MS/MS of BN-PAGE identification of multiple protein 
complexes containing PfHsp70x  
BN-PAGE has been widely used for studying protein-protein interactions in 
membranes, total cell and tissue (Schagger et al., 1994; Poetsch et al., 2000; Wittig et 
al., 2006). In P. falciparum studies, it has been successful used for investigation of 
proteasome complexes and PTEX translocon protein complex (de Koning-Ward et al., 
2009; Sessler et al., 2012; Beck et al., 2014).  In our study, we try to use BN-PAGE to 
isolate our protein complex. By coupling LC-MS/MS to BN-PAGE, PfHsp70x was 
identified with some exported proteins including PHISTb family protein, PfGEXP18, and 
PfGBP130, Which gives us a better idea of that PfHsp70x maybe involved into multiple 
protein complexes. Unfortunately, we couldn't find PFE55 in BN-PAGE. The possible 
reason for the lack of PFE55 is due to highly expressed proteins. Most of the proteins 
that were identified in these two bands belong to several high molecular weight protein 
complexes including Plamodium rhoptry neck (RON) protein complex and low and high 
rhoptry complexes protein complex (Cowman et al., 2012). 
 Protein-protein interaction identification by Co-4.2
immunoprecipitation (co-IP) and LC-MS/MS 
In order to investigation of components of protein complexes contains PFE55 and 
PfHsp70x, co-IP assays with anti-GFP and anti-PfHsp70x specific antisera were 
performed on in vivo cross-linked PFE55GFP transgenic parasites. The candidate 
interactions proteins were analysed by LC-MS/MS and immunoblotting, Although, J-
dots are found in the iRBC cytosol also many other proteins from different parasite 
compartments (e.g. parasitophorous vacuole) were found to bind the PFE55/PfHsp70x 
co-chaperone-chaperone complex. Therefore, in this study the focus was laid on 
parasitophorous vacuole and erythrocyte proteins. After selected the candidate 
proteins according to the subcellular localisation and peptide count ratio. It is not 
surprise that we found PFE55 identified only interact with six protein including 
PfHsp70x, while PfHsp70x identified interact with much more numbers of proteins. P. 
falciparum genome 43 members of Hsp40 family and only six members of Hsp70 
(Botha et al., 2007). Amongst of them, there are 19 members of Hsp40 compare to 
only one Hsp70 (Hsp70x) predicted exported to the erythrocyte cytosol. Therefore, 
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PfHsp70x appears to interact with a larger number of substrate proteins than PFE55 
(Botha et al., 2007)  
4.2.1 PfPHIST_0801 associates with PFE55 and PfHsp70x at J-
dots 
There are two proteins PfHsp101 and PF3D7_0801000, with different localizations, 
were co-predicated with both anti-GFP and anti-PfHsp70x. PfPHIST_0801 
(PF3D7_0801000) is a member of PHISTc family, which co-immunoprecipitated with 
both PFE55-GFP and PfHsp70x, with three- fold and nine- fold unique peptide 
identification compared to negative control, respectively. This was further verified by 
immunoblotting of co-IP and co-localization with PfHsp70x. Moreover, a western 
blotting of 2D BN/SDS PAGE was employed to confirm that PFE55-GFP, PfHsp70x 
and PfPHISTc belong to the same high molecular weight protein complex. Therefore, 
PfPHIST_0801 was suggested as the third component of the J-dot protein complex by 
associating with PFE55 and PfHsp70x in the infected erythrocyte cytosol.  
Except PfPHIST_0801, two more PHISTb family proteins PF3D7_1201000 and 
PF3D7_0401800 were identified by pull downs with PfHsp70x followed LC-MS/MS. 
The PHIST (Poly-Helical Interspersed Sub-Telomeric) family is a large protein family 
with 72 members and is divided into three sub-families including PHISTa, b, c 
(Sargeant et al., 2006). A recent study found that some of the PHIST family proteins 
are involved in knobs formation, in contrast to PHISTb (PF3D7_0401800) which is 
essential for the parasite survival (Maier et al., 2008; Tarr et al., 2014). The latest study 
showed that PHIST proteins are involved in PfEMP1 trafficking to the cell surface 
(Oberli et al., 2016). In our previous study, we suggested that J-dots are involved in 
PfEMP1 trafficking to the host cell based on the fact that PfEMP1 co-localized with 
Hsp70x during its transport (Kulzer et al., 2012), In this study, this hypothesis was 
further confirmed by the identification of several PHIST family proteins that interacted 
with PFE55/PfHsp70x. Unfortunately, in our study, PfEMP1 was not identified by LC-
MS/MS from co-IP neither with anti-GFP nor with anti-PfHsp70x. It is possible that 
PfEMP1 was not identified due to the stage dependent interaction of PfHsp70x and 
PfEMP1. In our previous study PfHsp70x and PfEMP1 showed a high co-localization at 
very early parasite stages (Kulzer et al., 2012). Moreover, PfEMP1 is a high molecular 
weight protein with low abundance, which makes it difficult to precipitate this protein. 
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As so many exported proteins were identified to associate with PfHsp70x it is likely for 
PfHsp70x to have a role in the delivery of proteins to their destinations.   
 
4.2.2 PfGEXP18 interacts with Hsp70x at the J-dots 
PfGEXP18 is an exported protein with unknown function and found to be expressed in 
early gametocyte stages and asexual blood stages (Aurrecoechea et al., 2009; 
Silvestrini et al., 2010). In our study, PfGEXP18 was identified interacted with 
PfHsp70x. Because of the lack of a specific antibody of PfGEXP18, a transgenic 
parasite cell line was generated that expressed a PfGEXP18-GFP fusion protein. 
During live cell image of the PfGEXP18GFP showed, highly mobile dots that had no 
fixed direction. Form the morphological point of view PfGEXP18 showed a J-dot like 
(Kulzer et al., 2012). Moreover, immunofluorescence assay showed that PfGEXP18 co-
localized with PfHsp70x, which indicates that PfGEXP18 is localized at J-dots by 
incorporation with PfHsp70x. However, because of lacking the function of PfGEXP18, 
therefore it is difficult to explain whether PfGEXP18 incorporate with J-dots protein as a 
partner or be trafficked by J-dots, and this is need to be further investigate in the future.   
 PfHsp70x associate with PTEX translocon 4.3
Hsp101/ClpB is belongs to HSP100 protein family, and found in many different species 
such as bacteria, plants and eukaryotic mitochondria with highly conserved sequences 
(Lee et al., 1994; Nieto-Sotelo et al., 1999; Doyle and Wickner, 2009). Hsp101/ClpB 
helps solubilize the aggregate protein formed during the heat stress (Doyle and 
Wickner, 2009). In addition, many studies found Hsp101/ClpB works incorporation with 
DnaK/Hsp70 chaperone for aggregate protein degradation (Goloubinoff et al., 1999; 
Zolkiewski, 1999; Doyle and Wickner, 2009). In our study, parasite-encoded PfHsp101 
was found to specifically interact with both PfHsp70x as well as PFE55 in co-IP, 
immunoblotting and co-localization assay. PfHsp101 is a component of the PTEX 
translocon which is localized in the parasitophorous vacuole membrane (de Koning-
Ward et al., 2009). The role of PfHsp101 in protein transport was predicated to be in 
co-operation with some other heat shock proteins to keep exported proteins unfolded, 
and then transport the protein cross the parasitophorous vacuole membrane by 
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passing through the pore formed by EXP2 (de Koning-Ward et al., 2009). Others and 
we have suggested that PfHsp70x helps in the protein transport by interacting with the 
PTEX translocon either at the -cis or -trans side of the parasitophorous vacuole 
membrane (Kulzer et al., 2012; Elsworth et al., 2016).  The exported proteins could be 
chaperoned by PfHsp70x to keep them unfolded to the PTEX by interaction with 
PfHsp101 or help the transport protein refolding after cross the parasitophorous 
vacuole membrane (de Koning-Ward et al., 2009; Kulzer et al., 2012). Although, some 
parasite encoded Hsp70s were predicated to interact with PfHsp101, only PfHsp70x 
was found in both parasitophorous vacuole and erythrocyte cytosol. This strongly 
suggests that PfHsp70x plays an important role in protein traffic cross parasitophorous 
vacuole membrane, by interacting with PfHsp101. In order to elucidate if PfHsp70x 
interacts with PfHsp101 in a cis- or trans- fashion, a protease K assay was used to 
digest residual PfHsp70x of the erythrocyte cytosol. Surprisingly, PfHsp101 was not 
identified in a pull down experiment with PfHsp70x after proteinase K treatment, which 
suggests that the interaction between PfHsp101 and PfHsp70x was broken down by 
the proteinase K treatment. PfHsp101 faces towards the parasitophorous vacuole and 
was thereby protected from protease K treatment which hints towards an indirect 
interaction of PfHsp101-PfHsp70x that is mediated by other parasitophorous vacuole 
membrane resident factors. Interestingly, another PTEX translocon component, 
exported protein 2 (EXP2), was identified and verified to interact with PfHsp70x by LC-
MS/MS and western blotting. PfEXP2 is a membrane associate protein forming a 
channel in the parasitophorous vacuole membrane by which unfolded proteins can 
pass to reach the erythrocyte cytosol (de Koning-Ward et al., 2009; Molloy, 2014). 
Therefore, it can be hypothesized that PfEXP2 mediates the binding between 
PfHsp70x (erythrocyte cytosol) and PfHsp101 (parasitophorous vacuole lumen). 
A recently study from Elsworth&Sander et al., identified PfPV1 and PfHsp70x in 
association with the PTEX translocon core component PTEX150, they suggested that 
PfHsp70x associates with PTEX at the erythrocyte side and might there be involved in 
the refolding of proteins after their path through the PTEX translocon (Elsworth et al., 
2016). These observations are consistent with our obtained data which identified an 
interaction between PfHsp70x and PfHsp101, possibly mediated by PfEXP2, at the 
trans-side of the parasitophorous vacuole membrane. So far, the function of the 
interaction between PfHsp70x and PTEX translocon is lacking in our study and we are 
generating several PfHsp70x knockdown transgenic parasite lines to reveal the 
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importance role of PfHsp70x in protein transport. 
 Other protein interactions with PfHsp70x in the 4.4
parasitophorous vacuole 
In this study, PFE55 and PfGBP130 were both identified as interaction partners of 
PfHsp70x in the lumen of parasitophorous vacuole. After proteinase K protection 
assay, a further verification of the already proven PFE55 interaction with PfHsp70x in 
iRBC cytosol was achieved (Kulzer et al., 2010; Kulzer et al., 2012). So far, the function 
of the PFE55-PfHsp70x complex in the parasitophorous vacuole is unknown. However, 
some hypothesis suggest that exported proteins could be chaperoned by parasite 
encoded Hsp70s/40s to keep them in an unfolded state or to unfold proteins before 
being delivered to PfHsp101 to pass through the parasitophorous vacuole membrane 
(Maier et al., 2008; Gehde et al., 2009). Whether the incorporate between the 
PfHsp70x and PFE55 support the protein transport through the PTEX translocon or not 
needs to be further analyzed.  
PfGBP130 is known as an exported protein localized in the parasitophorous vacuole 
and erythrocyte cytosol (Ansorge et al., 1996). PfGBP130 interacts with PfHsp70x in 
the parasitophorous vacuole as well as in the erythrocyte cytosol with anti-PfGBP130 
of 2D BN/SDS PAGE indicates that the PfGBP130-PfHsp70x protein complex is 
potential raised to a supercomplex by binding the J-dot protein complex.  
 PFE55 interaction with Human Hsp70 4.5
There is the long-standing question of a potential interaction of parasite-encoded type II 
Hsp40s and human Hsp70 chaperones before exported PfHsp70x found. Since 
parasite-encoded type II Hsp40s is homologous with the human DnaJB4, cooperation 
with human Hsp70s might be possible.. In order to address the question of an 
interaction between human hsp70 and PFE55, all of the raw data was search against 
human database. There were two HsHsp70 protein identified to interact with PFE55-
GFP, HSP74_HUMAN and GRP78_HUMAN, which was highly suggests a chimeric 
interaction PFE55 and human Hsp70. Also, a recently study of Hsp40 (PFA0660w) 
shows functionally interacts with PfHsp70x as a co-chaperone, but not the human 
Hsp70 (Daniyan et al., 2016) However, the chimeric chaperone-co-chaperone 
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complexes could assist parasite-exported proteins in refolding after traffic through the 
PTEX translocon has been described (Charpian and Przyborski, 2008; de Koning-Ward 
et al., 2009; Gehde et al., 2009). Therefore, in order to better understand the 
importance interaction between human Hsp70 and PFE55 in protein trafficking, a 
further study will be continued. 
 
         
 
Figure 4.1: Protein-protein interactions network with PfHsp70x/PFE55 model. 
JD: J-dot; red color: erythrocyte cytosol; yellow color: parasitophorous vacuole; IP: immunoprecipitation; 
WB: western blot; MS: mass spectrometry  
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 Summary and outlook  4.6
As the exported parasite-encoded proteins are responsible for many modifications of 
host cell, we are always interest in study of protein transporting in the infected iRBC. 
Our previously study found a parasite-encoded PfHsp70x was cooperate with parasite-
encoded Hsp40s (PFE55/PFA660) in the infected erythrocyte cytosol. Hsp40s 
(PFE55/PFA660) and PfHsp70x both are important chaperones and have been 
implicated involve in several cellular processes in host cell. In order to better 
understanding the functional of Hsp40 (PFE55) /Hsp70x chaperone/co-chaperones, In 
this study, we use multiple proteomics analysis method to study the protein-protein 
interaction and further construct a protein network of Hsp40 (PFE55) /Hsp70x.  
It is a challenge to study protein complex in Plasmodium falciparum infected red blood 
cell, a complicated proteome system which originates from two species. Therefore, 
multiple proteomic methods were carried to purify and characterize protein complexes 
containing PfHsp70x, e.g. BN-PAGE, 2D BN/SDS PAGE, co-immunoprecipitation (co-
IP). Surprisingly, PfHsp70x was found to be involved in a multi- protein complex, and 
Hsp70x protein interactions occurred in both erythrocyte cytosol and parasitophorous 
vacuole.  
In parasite infected erythrocyte cytosol, one protein complex was localized at J-dots 
including PFE55, PfHsp70x, PfPHIST_0801 and PfGEXP18. In our previous study, we 
found that PfEMP1 co-localized with PfHsp70x at J-dots, which implicated that J-dots 
play a role for the transport of PfEMP1 to host cell membrane. Unfortunately, so far, we 
are unable to immunoprecipitate PfEMP1 with PfHsp70x. Therefore, directly 
biochemical or genetic evidence to show the function of J-dots is still lacking.  However, 
we cannot exclude the PFE55-PfHsp70x-PHIST protein complex assists PfEMP1 in 
transport especially as two further PfPHISTb family proteins were identified as 
interaction partners of PfHsp70x. Therefore, the interaction and function between 
PfHsp70x and PHIST family protein needs to be further analyzed. So far, the functional 
of PfGEXP18 is lacking, it is difficult to interpret whether PfGEXP18 is a partners of J-
dots or only be trafficked by J-dots. We are trying to generate a PfGEXP18 knockdown 
parasite to demonstrate of these.  
Interestingly, PfHsp101 and PfEXP2 specifically bind PfHsp70x. In addition, the 
interaction between PfHsp70x and PfHsp101 spans the parasitophorous vacuole 
membrane and is mediated by PfEXP2. PfHsp101 and PfEXP2 are two essential 
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components of PTEX translocon, which is localized at parasitophorous vacuole 
membrane and are responsible for the transport of the protein from parasitophorous 
vacuole to the erythrocyte (de Koning-Ward et al., 2009). A very recent result showed 
that, another essential component of PTEX complex-PTEX 150 was found to interact 
with PfHsp70x (Elsworth et al., 2016). This leads to the hypothesis that PfHsp70x 
assists the PTEX translocon in protein transport. It is known that proteins need to be 
unfolded in order to pass through the translocon and later need to be refolded. This 
process it is assisted by chaperones/ co-chaperones. PfHsp70x is the only exported 
and parasite encoded Hsp70 found involved into multiple protein-protein interaction 
and further cooperated with PTEX translocon, which make us interpretation of 
PfHsp70x has the function of to coordinate protein trafficking. However, direct evidence 
is lacking. We will further investigate the importance of PfHsp70x relate to protein traffic 
by generating multiple PfHsp70x knockdown transgenic parasite lines.  
The discussion of human Hsp70 interaction with parasite encode Hsp40 have been 
generated for a long time. In our LC-MS/MS data, two human Hsp70 were identified to 
potentially interact with PFE55, However, due to high homology between human Hsp70 
and parasite encoded Hsps, it was difficult to verify with specific. Nevertheless, as 
Human Hsp70 also interpreted interaction with PTEX translocon, the interaction and 
function between Human Hsp70-PFE55-PfHsp70x-PTEX is need to be further analysis. 
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Table S1: Full list of proteome identification of co-immunoprecipitation against with anti-GFP by 
LC/MS/MS (Plasmodium DB database). 
Exported N=5 
Accession 
Number Protein names 
Unique 
Peptide 
Number 
Peptide 
Coverage 
Unique 
Peptide 
Number 
Peptide
Coverag
e 
Ratio 
 
PF3D7_0501100.
1/2 
heat shock protein 40, type II 
(HSP40) 6 15.42 0 0.00 6/0 
PF3D7_0801000 
Plasmodium exported protein 
(PHISTc), unknown function 3 4.10 0 0.00 3/0 
PF3D7_1401100 DnaJ protein, putative 8 22.56 1 1.83 8.00 
PF3D7_1407800 plasmepsin IV (PM4) 3 12.70 1 4.68 3.00 
PF3D7_0831700 
heat shock protein 70 (HSP70-
x) 17 34.87 6 15.46 2.83 
Signal peptide N=3 
PF3D7_1116800 
heat shock protein 101 
(HSP101) 5 9.27 0 0.00 5/0 
PF3D7_0929400 
high molecular weight rhoptry 
protein 2 (RhopH2) 7 7.33 4 5.01 1.75 
PF3D7_1471100 exported protein 2 (EXP2) 3 9.76 2 8.36 1.50 
TM Domain N=2 
PF3D7_1408100 plasmepsin III (HAP) 2 5.97 0 0.00 2/0 
PF3D7_1311800 
M1-family alanyl 
aminopeptidase (M1AAP) 7 11.43 6 9.68 1.17 
No signal N=31 
PF3D7_1361800 
conserved Plasmodium 
protein, unknown function 8 4.65 0 0.00 8/0 
PF3D7_1308200 
carbamoyl phosphate 
synthetase (cpsSII) 6 3.92 0 0.00 6/0 
PF3D7_1441400 
FACT complex subunit 
SSRP1, putative (FACT-S) 6 14.63 0 0.00 6/0 
PF3D7_0307100 
40S ribosomal protein S12, 
putative 4 36.88 0 0.00 4/0 
PF3D7_0517000 
60S ribosomal protein L12, 
putative 4 34.55 0 0.00 4/0 
PF3D7_1410600 
eukaryotic translation initiation 
factor 2 gamma subunit, 
putative 4 15.48 0 0.00 4/0 
PF3D7_1225800 
ubiquitin-activating enzyme E1 
(UBA1) 3 3.42 0 0.00 3/0 
PF3D7_1338100 
26S proteasome regulatory 
subunit RPN3, putative 
(RPN3) 3 8.95 0 0.00 3/0 
PF3D7_1027800 
60S ribosomal protein L3 
(RPL3) 2 7.77 0 0.00 2/0 
PF3D7_1103100 
60S acidic ribosomal protein 
P1, putative (RPP1) 2 22.03 0 0.00 2/0 
PF3D7_1136400 
signal recognition particle 
subunit SRP72, putative 
(SRP72) 3 5.08 0 0.00 2/0 
PF3D7_1238800 acyl-CoA synthetase (ACS11) 2 3.79 0 0.00 2/0 
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PF3D7_1367000 
suppressor of kinetochore 
protein 1, putative (SKP1) 2 14.82 0 0.00 2/0 
PF3D7_1369700 
U2 small nuclear 
ribonucleoprotein A', putative 2 12.57 0 0.00 2/0 
PF3D7_1203700 
nucleosome assembly protein 
(NAPL) 6 14.70 1 2.59 6.00 
PF3D7_1451100 elongation factor 2 (eEF2) 5 8.29 1 1.08 5.00 
PF3D7_1416500 
NADP-specific glutamate 
dehydrogenase (GDH1) 4 14.68 1 4.04 4.00 
PF3D7_0708800 
heat shock protein 110 
(HSP110c) 7 12.37 2 3.44 3.50 
PF3D7_0322000 
peptidyl-prolyl cis-trans 
isomerase (CYP19A) 3 18.13 1 7.02 3.00 
PF3D7_0708400 heat shock protein 90 (HSP90) 11 20.27 4 7.38 2.75 
PF3D7_1441200 
60S ribosomal protein L1, 
putative 2 13.36 1 5.53 2.00 
PF3D7_0802000 
glutamate dehydrogenase, 
putative (GDH3) 5 3.94 3 2.51 1.67 
PF3D7_1436000 
glucose-6-phosphate 
isomerase (GPI) 5 11.92 3 6.39 1.67 
PF3D7_1011800 PRE-binding protein (PREBP) 3 2.81 2 1.93 1.50 
PF3D7_1034900 
methionine--tRNA ligase 
(MRScyt) 3 4.50 2 3.15 1.50 
PF3D7_1341200 
60S ribosomal protein L18, 
putative 3 14.67 2 7.61 1.50 
PF3D7_1460700 
60S ribosomal protein L27 
(RPL27) 3 20.55 2 15.07 1.50 
PF3D7_0818900 heat shock protein 70 (HSP70) 12 16.54 9 17.43 1.33 
PF3D7_1357800 
T-complex protein 1 subunit 
delta (CCT4) 4 11.34 3 13.04 1.33 
PF3D7_1444800 
fructose-bisphosphate 
aldolase (FBPA) 9 24.39 7 26.83 1.29 
PF3D7_0621200 
pyridoxine biosynthesis protein 
PDX1 (PDX1) 6 28.24 5 28.24 1.20 
 
 
Table S2: Full list of proteome identification of co-immunoprecipitation against with anti-PfHsp70x by 
LC/MS/MS (Plasmodium DB database). 
Exported N=9 
Accession 
Number Protein names 
Unique 
Peptide 
Number 
Peptide 
Coverage 
Unique 
Peptide 
Number 
Peptide
Coverag
e 
Ratio 
 
PF3D7_0831700 
heat shock protein 70 (HSP70-
x) 38 57.44 3 12.08 12.67 
PF3D7_0402400 
Plasmodium exported protein, 
unknown function (GEXP18) 6 36.61 0 0.00 6/0 
PF3D7_1016300 
glycophorin binding protein 
(GBP) 6 46.48 0 0.00 6/0 
PF3D7_0501100.
1/2 
heat shock protein 40, type II 
(HSP40) 4 15.92 0 0.00 4/0 
PF3D7_1201000 
Plasmodium exported protein 
(PHISTb), unknown function 4 6.28 0 0.00 4/0 
PF3D7_0401800 
Plasmodium exported protein 
(PHISTb), unknown function 2 4.46 0 0.00 2/0 
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(PfD80) 
PF3D7_0721100 
conserved Plasmodium 
protein, unknown function 2 9.84 0 0.00 2/0 
PF3D7_1001400 alpha/beta hydrolase, putative 2 3.47 0 0.00 2/0 
PF3D7_0801000 
Plasmodium exported protein 
(PHISTc), unknown function 9 12.22 0 0.00 9/0 
Signal peptide N=3 
PF3D7_1252100 rhoptry neck protein 3 (RON3) 9 5.60 0 0.00 9/0 
PF3D7_1012200 
conserved Plasmodium 
protein, unknown function 5 24.72 0 0.00 5/0 
PF3D7_1116800 
heat shock protein 101 
(HSP101) 4 6.51 0 0.00 4/0 
PF3D7_1105800 
conserved Plasmodium 
protein, unknown function 3 13.53 0 0.00 3/0 
PF3D7_0302500 
cytoadherence linked asexual 
protein 3.1 (CLAG3.1) 2 3.25 0 0.00 2/0 
PF3D7_1015200.
1/2 
cysteine--tRNA ligase, putative 
(CysRS) 2 3.40 0 0.00 2/0 
PF3D7_1116000 rhoptry neck protein 4 (RON4) 2 1.67 0 0.00 2/0 
PF3D7_0930300 
merozoite surface protein 1 
(MSP1) 11 8.37 1 2.85 11.00 
PF3D7_0207600 
serine repeat antigen 5 
(SERA5) 8 15.15 1 1.81 8.00 
PF3D7_1232100 60 kDa chaperonin (CPN60) 8 19.36 1 1.67 8.00 
PF3D7_0827900 
protein disulfide isomerase 
(PDI8) 5 18.63 1 3.42 5.00 
PF3D7_0917900 
heat shock protein 70 (HSP70-
2) 19 36.35 4 7.36 4.75 
PF3D7_0929400 
high molecular weight rhoptry 
protein 2 (RhopH2) 25 25.04 6 6.39 4.17 
PF3D7_1471100 exported protein 2 (EXP2) 4 14.98 1 3.83 4.00 
PF3D7_1222300 
endoplasmin, putative 
(GRP94) 7 12.42 2 3.41 3.50 
PF3D7_0905400 
high molecular weight rhoptry 
protein 3 (RhopH3) 11 19.84 4 6.24 2.75 
PF3D7_1129100 
parasitophorous vacuolar 
protein 1 (PV1) 5 14.82 2 5.75 2.50 
PF3D7_1454400 aminopeptidase P (APP) 17 29.09 8 13.26 2.13 
PF3D7_1010700 
dolichyl-phosphate-mannose 
protein mannosyltransferase, 
putative 3 18.39 2 16.55 1.50 
PF3D7_1324900 
L-lactate dehydrogenase 
(LDH) 13 51.58 9 56.96 1.44 
TM Domain N=8 
PF3D7_0811200 
ER membrane protein 
complex subunit 1, putative 
(EMC1) 4 5.21 0 0.00 4/0 
PF3D7_0220000 liver stage antigen 3 (LSA3) 3 2.95 0 0.00 3/0 
PF3D7_0823800 DnaJ protein, putative 3 8.40 0 0.00 3/0 
PF3D7_1037300 
ADP/ATP transporter on 
adenylate translocase (ADT) 3 15.62 0 0.00 3/0 
PF3D7_1105800 
conserved Plasmodium 
protein, unknown function 3 13.53 0 0.00 3/0 
PF3D7_1459400 
conserved Plasmodium 
protein, unknown function 2 7.94 0 0.00 2/0 
PF3D7_1311800 
M1-family alanyl 
aminopeptidase (M1AAP) 12 17.51 1 2.58 12.00 
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PF3D7_0801800 
mannose-6-phosphate 
isomerase, putative 2 2.57 1 1.09 2.00 
No signal N=31 
PF3D7_1034900 
methionine--tRNA ligase 
(MRScyt) 11 15.97 0 0.00 11/0 
PF3D7_1410200 
cytidine triphosphate 
synthetase 11 17.13 0 0.00 11/0 
PF3D7_0205900 
26S proteasome regulatory 
subunit RPN1, putative 
(RPN1) 8 13.35 0 0.00 8/0 
PF3D7_1104000 
phenylalanine--tRNA ligase 
beta subunit 8 22.31 0 0.00 8/0 
PF3D7_1145400 dynamin-like protein (DYN1) 8 10.63 0 0.00 8/0 
PF3D7_1453800 
glucose-6-phosphate 
dehydrogenase-6-
phosphogluconolactonase 
(GluPho) 8 10.99 0 0.00 8/0 
PF3D7_0525100 acyl-CoA synthetase (ACS10) 7 14.41 0 0.00 7/0 
PF3D7_1355100 
DNA replication licensing 
factor MCM6 (MCM6) 7 9.58 0 0.00 7/0 
PF3D7_1012600 GMP synthetase (GMPS) 6 14.78 0 0.00 6/0 
PF3D7_1417800 
DNA replication licensing 
factor MCM2 (MCM2) 6 12.46 0 0.00 6/0 
PF3D7_0305500 
conserved Plasmodium 
protein, unknown function 5 1.65 0 0.00 5/0 
PF3D7_0822600 
protein transport protein 
SEC23 (SEC23) 5 12.52 0 0.00 5/0 
PF3D7_1117700 
GTP-binding nuclear protein 
RAN/TC4 (RAN) 5 33.18 0 0.00 5/0 
PF3D7_1134000 
heat shock protein 70 (HSP70-
3) 5 16.14 0 0.00 5/0 
PF3D7_1224300 
polyadenylate-binding protein, 
putative (PABP) 5 8.57 0 0.00 5/0 
PF3D7_1317100 
DNA replication licensing 
factor MCM4 (MCM4) 5 9.85 0 0.00 5/0 
PF3D7_0803800 
proteasome subunit beta type-
4 4 20.00 0 0.00 4/0 
PF3D7_0808400 
coatomer subunit epsilon, 
putative (SEC28) 4 17.27 0 0.00 4/0 
PF3D7_1136300 
tudor staphylococcal nuclease 
(TSN) 4 4.10 0 0.00 4/0 
PF3D7_1353900 
proteasome subunit alpha 
type-7, putative 4 24.07 0 0.00 4/0 
PF3D7_1437900 
HSP40, subfamily A, putative 
(ERdj3) 4 16.75 0 0.00 4/0 
PF3D7_1464900 
ATP-dependent zinc 
metalloprotease FTSH, 
putative 4 8.78 0 0.00 4/0 
PF3D7_1474800 
proteasome subunit alpha 
type-1, putative 4 27.17 0 0.00 4/0 
PF3D7_0527000 
DNA replication licensing 
factor MCM3, putative (MCM3) 3 4.16 0 0.00 3/0 
PF3D7_0903400 
DEAD/DEAH box helicase, 
putative 3 1.62 0 0.00 3/0 
PF3D7_1008400 
26S protease regulatory 
subunit 4, putative (RPT2) 3 6.03 0 0.00 3/0 
PF3D7_1008700 tubulin beta chain 3 8.76 0 0.00 3/0 
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PF3D7_1008900 adenylate kinase (AK1) 3 18.60 0 0.00 3/0 
PF3D7_1127100 
deoxyuridine 5'-triphosphate 
nucleotidohydrolase 
(dUTPase) 3 22.54 0 0.00 3/0 
PF3D7_1130400 
26S protease regulatory 
subunit 6A, putative (RPT5) 3 7.75 0 0.00 3/0 
PF3D7_1208900 protein phosphatase, putative 3 3.33 0 0.00 3/0 
PF3D7_1213800 proline--tRNA ligase (PRS) 3 5.63 0 0.00 3/0 
PF3D7_1235700 
ATP synthase subunit beta, 
mitochondrial 3 9.28 0 0.00 3/0 
PF3D7_1239000 
HD superfamily 
phosphohydrolase protein 3 8.04 0 0.00 3/0 
PF3D7_1250700 
conserved Plasmodium 
protein, unknown function 3 24.86 0 0.00 3/0 
PF3D7_1402300 
26S proteasome regulatory 
subunit RPN6 (RPN6) 3 6.31 0 0.00 3/0 
PF3D7_1451100 elongation factor 2 (eEF2) 3 4.69 0 0.00 3/0 
PF3D7_0109200 
mRNA cleavage factor-like 
protein, putative 2 15.09 0 0.00 2/0 
PF3D7_0109500 N-acetyltransferase, putative 2 16.77 0 0.00 2/0 
PF3D7_0211800 
asparagine--tRNA ligase 
(AsnRS) 2 3.28 0 0.00 2/0 
PF3D7_0315100 
eukaryotic translation initiation 
factor 4E (eIF4E) 2 7.05 0 0.00 2/0 
PF3D7_0319600 
elongation factor 1 (EF-1), 
putative 2 20.51 0 0.00 2/0 
PF3D7_0416800 small GTP-binding protein 
sar1 (SAR1) 2 15.63 0 0.00 2/0 
PF3D7_0529500 
cell cycle regulator protein, 
putative 2 15.08 0 0.00 2/0 
PF3D7_0619500 acyl-CoA synthetase (ACS12) 2 2.30 0 0.00 2/0 
PF3D7_0807500 
proteasome subunit alpha 
type-6, putative 2 8.85 0 0.00 2/0 
PF3D7_0826700 
receptor for activated c kinase 
(RACK) 2 6.50 0 0.00 2/0 
PF3D7_0933600 
mitochondrial-processing 
peptidase subunit beta, 
putative (MAS1) 2 5.79 0 0.00 2/0 
PF3D7_1012700 
NLI interacting factor-like 
phosphatase, putative (NIF4) 2 1.53 0 0.00 2/0 
PF3D7_1015200.
3 cysteine--tRNA ligase, putative 2 3.40 0 0.00 2/0 
PF3D7_1034400 
flavoprotein subunit of 
succinate dehydrogenase 
(SDHA) 2 4.12 0 0.00 2/0 
PF3D7_1106000 RuvB-like helicase 2 (RUVB2) 2 4.00 0 0.00 2/0 
PF3D7_1126200 
40S ribosomal protein S18, 
putative 2 23.72 0 0.00 2/0 
PF3D7_1206700 
eukaryotic translation initiation 
factor 5, putative 2 4.60 0 0.00 2/0 
PF3D7_1211700 
DNA replication licensing 
factor MCM5, putative (MCM5) 2 3.96 0 0.00 2/0 
PF3D7_1231100 
ras-related protein Rab-2 
(RAB2) 2 11.74 0 0.00 2/0 
PF3D7_1239600 
hydroxyethylthiazole kinase 
(ThzK) 2 3.16 0 0.00 2/0 
PF3D7_1247400 FK506-binding protein (FKBP)- 2 9.54 0 0.00 2/0 
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type peptidyl-prolyl isomerase 
(FKBP35) 
PF3D7_1251300 thymidylate kinase (TMK) 2 9.05 0 0.00 2/0 
PF3D7_1323100 
60S ribosomal protein L6, 
putative 2 18.42 0 0.00 2/0 
PF3D7_1338100 
26S proteasome regulatory 
subunit RPN3, putative 
(RPN3) 2 11.53 0 0.00 2/0 
PF3D7_1341900 
V-type proton ATPase subunit 
D, putative 2 7.29 0 0.00 2/0 
PF3D7_1342800 
phosphoenolpyruvate 
carboxykinase (PEPCK) 2 4.12 0 0.00 2/0 
PF3D7_1346300 
DNA/RNA-binding protein Alba 
2 (ALBA2) 2 11.37 0 0.00 2/0 
PF3D7_1346400 
conserved Plasmodium 
protein, unknown function 2 0.38 0 0.00 2/0 
PF3D7_1353800 
proteasome subunit alpha 
type-4, putative 2 19.51 0 0.00 2/0 
PF3D7_1361100 
protein transport protein 
Sec24A (SEC24A) 2 3.40 0 0.00 2/0 
PF3D7_1419300 
glutathione S-transferase 
(Schweizer et al.) 2 11.37 0 0.00 2/0 
PF3D7_1420600 
pantothenate kinase, putative 
(PANK) 2 4.62 0 0.00 2/0 
PF3D7_1426700 
phosphoenolpyruvate 
carboxylase (PEPC) 2 2.53 0 0.00 2/0 
PF3D7_1445100 histidine--tRNA ligase, putative 2 2.12 0 0.00 2/0 
PF3D7_0802000 
glutamate dehydrogenase, 
putative (GDH3) 15 16.75 0 0.00 15 
PF3D7_0708800 
heat shock protein 110 
(HSP110c) 13 23.60 0 0.00 13/0 
PF3D7_1219100 clathrin heavy chain, putative 11 7.26 1 0.60 11.00 
PF3D7_1357800 
T-complex protein 1 subunit 
delta (CCT4) 11 29.68 1 28.92 11.00 
PF3D7_0922600 glutamine synthetase, putative 9 23.76 1 2.03 9.00 
PF3D7_1011800 PRE-binding protein (PREBP) 9 8.17 1 1.05 9.00 
PF3D7_1235600 
serine 
hydroxymethyltransferase 
(SHMT) 8 19.36 1 1.67 8.00 
PF3D7_0524000 karyopherin beta (KASbeta) 7 9.17 1 1.16 7.00 
PF3D7_0818200 14-3-3 protein (14-3-3I) 7 38.93 1 6.87 7.00 
PF3D7_0708400 heat shock protein 90 (HSP90) 12 24.16 2 5.64 6.00 
PF3D7_0932300 
M18 aspartyl aminopeptidase 
(M18AAP) 6 15.79 1 2.46 6.00 
PF3D7_0627800 
acetyl-CoA synthetase, 
putative (ACS) 5 6.62 1 1.00 5.00 
PF3D7_1403900 
serine/threonine protein 
phosphatase CPPED1, 
putative (CPPED1) 5 17.11 1 4.03 5.00 
PF3D7_1350100 lysine--tRNA ligase (KRS1) 9 17.84 2 4.29 4.50 
PF3D7_1325100 
phosphoribosylpyrophosphate 
synthetase 4 13.27 1 4.12 4.00 
PF3D7_1349200 
glutamate--tRNA ligase, 
putative 4 5.68 1 1.39 4.00 
PF3D7_1362200 RuvB-like helicase 3 (RUVB3) 4 14.49 1 3.31 4.00 
PF3D7_1436000 
glucose-6-phosphate 
isomerase (GPI) 8 18.48 2 3.80 4.00 
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PF3D7_1026800 
40S ribosomal protein S2 
(RPS2) 7 38.78 2 11.41 3.50 
PF3D7_1015600 heat shock protein 60 (HSP60) 10 26.72 3 6.55 3.33 
PF3D7_0214000 
T-complex protein 1 subunit 
theta (CCT8) 3 5.35 1 2.77 3.00 
PF3D7_0517000 
60S ribosomal protein L12, 
putative 3 28.49 1 15.15 3.00 
PF3D7_0934500 
V-type proton ATPase subunit 
E, putative 3 11.49 1 5.53 3.00 
PF3D7_1438900 
thioredoxin peroxidase 1 (Trx-
Px1) 3 27.18 1 21.03 3.00 
PF3D7_1470900 
proteasome subunit beta type-
2, putative 3 23.59 1 11.68 3.00 
PF3D7_0915400 6-phosphofructokinase (PFK9) 42 40.41 15 12.41 2.80 
PF3D7_0619400 
cell division cycle protein 48 
homologue, putative 5 8.82 2 3.62 2.50 
PF3D7_1229500 
T-complex protein 1 subunit 
gamma (CCT3) 10 23.06 4 7.57 2.50 
PF3D7_1311900 
V-type proton ATPase catalytic 
subunit A (vapA) 5 14.08 2 7.04 2.50 
PF3D7_1338200 
60S ribosomal protein L6-2, 
putative 5 31.22 2 13.12 2.50 
PF3D7_1447000 40S ribosomal protein S5 5 20.96 2 8.09 2.50 
PF3D7_1120100 
phosphoglycerate mutase, 
putative (PGM1) 7 45.20 3 12.00 2.33 
PF3D7_1343000 
phosphoethanolamine N-
methyltransferase (PMT) 14 70.68 6 29.70 2.33 
PF3D7_1012400 
hypoxanthine-guanine 
phosphoribosyltransferase 
(HGPRT) 11 56.28 5 41.99 2.20 
PF3D7_0322900 
40S ribosomal protein S3A, 
putative 2 11.45 1 9.16 2.00 
PF3D7_0516200 40S ribosomal protein S11 2 18.54 1 18.54 2.00 
PF3D7_0727400 
proteasome subunit alpha 
type-5, putative 2 13.67 1 4.69 2.00 
PF3D7_0813900 
40S ribosomal protein S16, 
putative 4 32.64 2 15.97 2.00 
PF3D7_0907700 
subunit of proteaseome 
activator complex, putative 4 16.85 2 10.04 2.00 
PF3D7_0920800 
inosine-5'-monophosphate 
dehydrogenase (IMPDH) 2 7.06 1 2.35 2.00 
PF3D7_1357900 
pyrroline-5-carboxylate 
reductase 2 12.98 1 12.21 2.00 
PF3D7_1439900 
triosephosphate isomerase 
(TIM) 6 33.47 3 21.37 2.00 
PF3D7_1441200 
60S ribosomal protein L1, 
putative 2 11.06 1 5.53 2.00 
PF3D7_1460700 
60S ribosomal protein L27 
(RPL27) 2 15.07 1 13.70 2.00 
PF3D7_0818900 heat shock protein 70 (HSP70) 9 16.25 5 16.25 1.80 
PF3D7_0621800 
nascent polypeptide 
associated complex alpha 
chain, putative 5 42.39 3 23.91 1.67 
PF3D7_1446200 
M17 leucyl aminopeptidase 
(LAP) 8 17.03 5 15.87 1.60 
PF3D7_1410600 
eukaryotic translation initiation 
factor 2 gamma subunit, 3 9.68 2 9.46 1.50 
Supplement 
104 
 
putative 
PF3D7_0621200 
pyridoxine biosynthesis protein 
PDX1 (PDX1) 4 13.29 3 22.26 1.33 
PF3D7_0608800 
ornithine aminotransferase 
(Tobie and Coatney) 5 12.56 4 13.53 1.25 
PF3D7_1357000 elongation factor 1-alpha 10 23.25 8 24.15 1.25 
PF3D7_1462800 
glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 16 59.05 13 62.32 1.23 
PF3D7_1444800 
fructose-bisphosphate 
aldolase (FBPA) 6 20.87 5 25.75 1.20 
PF3D7_1015900 enolase (Waterkeyn et al.) 15 42.60 13 62.78 1.15 
PF3D7_1105400 
40S ribosomal protein S4, 
putative 2 13.79 6 27.59 0.33 
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